がんとともに生きる

!"
#$%& '() *P L WC( P eo pl e Liv ing W ith Cancer: " ++, -./ 0)12 3
45-6 789 :;* <=> ?@A B 2007 C 8 DE F
GH
I JK-LMN*!")OP-Q,RSTU;0"VBWXY">ZSE*OP-LMN
Y"Y[\]^+_N`"-aMV 2 bc Vd0FeP-,!")fg_h0i*eP!
")jV*k!"glY 1%mnVd0F
I !o)*p-qrst-6uNvw:;0Fxy)z{Y|}~•€%V*•Yz{)*
!z>‚ƒ„{+…†;0„:M‡ˆv‰-6uNvw:;0F„:M‡iz*„{L6
Šz{>‹Œ•*z{ŽU!•B!oY!•>‘7’S“”•–y—EY˜™-š›œ0
!••+ž!>Ÿ
F¡‡L6Š¢(£‡i!o˜MA0+•¤>¥7*¡¦i§¨-©
ª>ŸŠ*¢(£&«¬-i®xY¯°±>²³œ0F¢(£‡)¢(£´-‹ŒiuN
M0F
I !")*kglYµ 90%i*!‡¶A)z{ŽU·¶0F!"k®Yµ 75%i!‡>¸
¹ºœ0§¨ŽU·¶7*!‡"+…†;0Fz„{ŽU·¶0")„{"+…†;0F
»¼i‡Y½-¾i7*¿Àst-¶VÁ_AÂÃ*ÄÅP¶A)ÆÇP!‡"+…†;
0F»¼i„{Y½È-¾iuAÂÃ*ÄÅP¶A)ÆÇP„{"+…†;0F»¼i¾
iuNMŒMÂÃ*ÉÊËÂÌVÍ+MhÎÏV*in situ ¶A)ÐÆÇP+…†;0FÐ
ÆÇP»¼YÑÒL6ŠÓYÔÕ)*ÐÆÇPz‡"BDucatal carcinoma in situ:DCISE
ŽÐÆÇP„{"BLobular carcinoma in situ:LCISEŽ-60F
I Ö×*ØÙÚÛÜ)*ÐÆÇP!"YÝRÞ>ßà0 DCIS -‹MN*ÆÇP!"-¼
á_A7*!o¶A)â®YãŒy—-¾iuA7œ0•+YŒM6h*äåæZœ0•
+>çè_NM0FDCIS -)*äå-éêN*ëìíÕîL6Šïðñ(Õî,çè:;
0•+,d0F
I LCIS )"+)òŒ:;”*Üó)ÑÒôõ+œ0•+iRMFLCIS )!"Yö÷^ø
Vd0Bö÷^øY$%&'(>ùúEF
I û-*RS)ŒMi*üˆ*ý¦*‡þ*á.P¶A)!•þ!"Œÿ,!"U;0F
#gP!")$%&'Y&M"V*!"k®Yµ 1%(5%>ßà0F!oiØ;di7*
!oYWXi)SŒ0•+iRMAà*!oY*+g+,-uN./:;0ÂÃid0F
0€12}~»)ÐÆÇP"Y34V*!•Y!‡ŽU·¶0FWX)RSYÂÃh¤•
iY6h-òê0•+iRS*Ž5T>6hÂÃ,d0F
I ")78ø9:>;œ0 1 <Y§¨ŽU·¶0+=êU;0F
•Y 1 <Y§¨i—>_*
‹M-)ØÙB§¨Y?E+Œ7*ÓY$%>@@0Aà-©ª>Aê0¡¦YBC>D
·œ0Fd0EF-Œ0+*§¨)QGY?ŽUH;*®xYûYyš•IJœ0•+i
d7*•;iKI+…†;0ÒLY3yVd0F
1
I !"§¨i¡‡M¢(£‡>N_N®xYûYyš•IJœ0+*!"iO¤iuNM
SF6Sd0KIyši¢(£´Vd0FPQBPYRE*SyBTE¶A)UVWBU
VYWE¢(£´i=êU;0FQ,6Sd0XYKIyšiV*`L6ŠZ[Vd0F
\')]SŒMi*!"i^-KIœ0ÂÃ,d0F")_ÌV,`fBÔÕa-"i
7bœ•+E_*WX*Ê3!oBÔÕVc³:;NMŒŽuAÂÃE*ûYdest¶
A)®xYÿ•ŽV`f_h0F
I !")KIi.Ë0f-./L6ŠÔÕigh;0ÂÃ,d0FJKKi"jkÌ
BNational Cancer Institute: NCIEYQlm€n-60+*!"Y 61%)"i!ox-o
¶uNM0,-./:;*31%)"i¢(£´pq¶A)!oYœr½-¾iuNŽU./
:;*6%)KIi.ËNŽU./:;NM0F
st
I 2007 C*JKV 178,480 uYOPiÆÇP!"+./:;*62,030 uiÐÆÇP!"+
./:;0+çv:;0FJKV)eP 2,030 ui!"+./:;0+çv:;0FÊC
- 40,910 uBOP 40,460 u*eP 450 uEi!"YAà[\œ0+çv:;0F
I "i!o-wv:;0ÂÃ*5 Cxy.z{B"i|³:;NŽU 5 C}W.zœ0~•
Y€{*A–_*û•~-60[\l)ZSE) 98%Vd0FÌ‚¢(£´-KI_AÂ
ÃY 5 Cxy.z{) 83%Vd0F"iXYKI_AÂÃY 5 Cxy.z{) 26%Vd0F
"iƒg_A„…Vfò:;A+_N,*l_MÔÕî-6uN*RÞY!"~•i*.
/f+ÊË.†Y‡>ˆ‰œ0•+iŠ‹Vd0F
I •;UYŒ)•ŽŒVd0•+-•Μ0•+i•HV*‘<uY¢«%)*ØÙYÝ
/:M’P¢(£´B"YÆÇY=àU;0¢(£´EYÞ+MuARÞYH“-”zœ
0FØÙ•–—i„:S*˜P¢(£´B"YÆÇY=àU;ŒM¢(£´EYÂÃ).
z{i]S*`fœ0Š‹P)™MFØÙY•–—iÝ/SŒ7*’P¢(£´YÞi$
ê0+`f{)$Ýœ0F
I 1990 C}š*!"YAà[\œ0OPYÞ)›Cœ•-žŸ_NM0F50
V)*1 C-‹/ 3.3%Y>ÃVžŸ_*50
mnYOP
}WYOPV)*1 C-‹/ 2%Y>ÃVž
Ÿ_N/AFÖ×*JKV)!"+./:;*ÔÕ>?@NM0OPi 200 ¡u¢.z_
NM0F
I ".z{-£œ0stY¤¥-)•Îi¦HVd0F•;UYçv)*›CJK-L@
0•Y4Y"YglÞ§l—YglŽU¨Am€n-©ªMNM0i*Ó;«;Y<uL@0•¬Y¢«%)9Œ0+-h;0F!"+./:;A~•:•-ÿ;–@./U;
0Ž>®"0•+)Š‹Œ•+V)ŒMF.z{Yst) 5 C›BE- 1 C›E-t¯:
;NM0Aà*•Y"YÔÕM./-L@0ƒ°>±²_ŒMÂÃ,d0F
stŒ)JK"³5³´*Cancer Facts & FigureB"Y•¬+ÞŒE2007 ŽUµ¼F
2
•Y$%&'(V¶·:;0"·¸-‹MN³ŠAMÂÃ*PLWC ¹2º»¼½uNL
/AM"ÚÛ·¸¼©¾¿ØÙ³·¸>3À:;AMF
ö÷^ø
I ö÷^ø+)*"if.œ0Š‹P>$Ý:Á0,YVd0FÂÃY6h-*Ä´Š‹
Œö÷^øid;†*CÅMÆÇÈY6h-Ä´É‹Œö÷^ø,d0Fö÷^ø)f"
-ÊË>ÌÍœ•+)d0i*ÎÏ">Ð/Ñ•œ•+)Ò+•ÿŒMFMS‹ŽYö÷
^ø>‰uNMN,"-ŒUŒMuiM;†*½U;NM0ö÷^ø>‰uNMŒSN,
"-Œ0u,M0F_Ž_*Ó—Yö÷^ø>½7*Ô#Ü-ÓY•+>8ê0•+-6
7*Õ—ŒÖ×>¨AWVY.†ˆØL6ŠÜÕ-‹MNYÙÚ>œ0•+iV/0F
I !")*RSYÂÃ*ÛÜŒö÷^øYŒMOP-LMNf.œ0F‹¶7*OP)!
o-¼ái.Ë0Š‹Pid0•+>=Ý_*!oYÞß.L6Šà(ñáâ-Bß.V
)|³_¨ŒM„:ŒØÙ,|³V/0!oY X íãäE>/º•+gh¦Hid0F!
"f.-)RÞYö÷^øiÊËœ06h--h;0F}RY^øi!"f.¢«%>$
Ý_h0F
CÅå!"f.¢«%)OPYCÅ+æ-$Ý_*Ò+•ÿi 50
>çêAOPV.ËN
M0F
u4 å ÜuOPYèi!"f.éê)]Mi*!"-67[\œ0éê)“uOPYèi
]MF.[>—@0ÓYûYëì)—ŽuNMŒMi*LÓUSí5Ñî¿^øL6Š.
±³¿^øYïèi£Aœ0+-h;0F
!"Y< u¿» Èå3èY!o-!"i.ËAOPV)*±yÈY!o-!"if.œ0
¢«%i›C 1%(2%”‹]SŒ0F
!"YÆ ÇÈå!"+./:;Að3ñqò•Bž*óô*õEiM0OP)*!"¢«
%i]MFðöñ}XYqò•-!"id0ÂÃ*Ó;i¹-÷Ñf-fg_NM0ÂÃ*
¢«%i]SŒ0F
78¿“ ^å!"78ø 1 ¶A) 2BBRCA1 ¶A) BRCA2EYøù¼9-6uN!"¢
«%i$Ýœ0F•;U78øYú½øù¼9-£_N*¡¦|9iû·V/0i*üV,çè:;0,YV)ŒS*ýæŒ78þÿ($¢(á>?@Aa-wU;0FjkŽ
U)*78¿ëì-60!")*!"k®Y 5%(10%-Ò•ŒM+çv:;NM0F!"
Y78³-‹MN*d+V!_S³
F
"#"Y <u¿ »ÈF"#",ïðñ($%-£&œ0Aà*"#"Y»Èid0OPY
!"¢«%)$Ý_h0FBRCA1 ¶A) BRCA2 ŒÿY!"78øYøù¼9-6uN*
"#"L6Š!"ïèY¢«%i$Ýœ0+=êU;0F
'«~( )($ %F'«~()()*öaP*YfÁB!oYfÁŒÿE>Ä´œ0OP
ïðñ(Vd0FOPY'«~()(+.)*÷ÑVžŸœ0F,-,Y'«~()($
%-6uN!"¢«%i$Ýœ0+*Üó)=êNM0F
3
.12
¶V-DÑi·¶uAOP¶A) 55
>Ò•N÷Ñ_AOP)*!o§¨i,-,
'«~()(-$%:;0Aà*!"¢«%i]MF
.30
>Ò•NŽU)ËàNY/0>_AOP¶A)n-+>Ñ1_A•+YŒMOPV
)!"¢«%i]MF/0)*!o§¨>Q2w3„…-4_ƒà0Aà*!"ŽU5u
NS;0+-h;0F
.QqBÒ6 5 C}xEYïðñ(78ÕîBHormone Replacement Therapy: HRTEY
¶·L6Š HRT Y,-¶·BÞC,}WE-6uNOPY!"¢«%)$Ýœ0F
!o Y9 9 Ò: w F •Yþ;-6uN!"¢«%)$Ýœ0FÓY¹*)*!o.|V*
9:Œ*A–_"V)ŒM§¨i|³:;0•+Vd0F
ÐÆÇP „{"B LC ISEFGHY$%&'(V<Û_A6h-*•;)!oY„{¶A
)zV9:§¨i|³:;0þ;Vd0FLCIS )ÆÇP!"B¿=st•¾i0"Ef.
¢«%>$Ý:Á0F•Yþ;>>Þœ0Q?Yèî>Üó+@_Ãh•+F
.†ˆØ ^ø FûY"+ÊËV*ˆAŒ.†ˆØ^øi!"fgY3^+Œ0•+iB1
ŽUÐ/@/C:;NM0F
.DnFQqYB1ŽU*Dn¶A)E7œ•i!"¢«%>$Ý:Á0•+iC:;N
M0F
.ŸJÉFFŸJ)ïðñ(G'>™R:Á*HIJ>¢à0FŸJÉF)DnY3^V
d0F
.KLF1 M-3N>çê0KL-6uN!"¢«%i]SŒ0+=êU;0F
ëì íF ]íOëìí-6uN*OPY!"¢«%)$Ýœ0+=êU;0F]PY,.z•*¢(£ØYAàdyëìíÔÕ>?@Au*X íúì>Q',?@AuBRSYA
à*d0M)Tzdz»¼M-/ŠYÔÕYAàŒÿE*UVYÐWPB"VŒME•~
L6ŠÜXYÔÕ-ëìíúì>?@A„Y-LMN*!"¢«%Y$Ýiôõ:;NM
0F
Z[
I Ö×Y+•¤*!"Z[î+_N\Û:;A,Y)ŒMi*3yYOP-y_N*!"
¢«%>]žœ0èî)d0F
.¹-¢M!"YÆÇÈ>;œ0OP-y_NBBRCA øù¼9ŒÿE*Z[¿!oæZ
B!oYZ[¿Z6Ei=êU;0F•Y•+-6uN*!">fgœ0¢«%iQ™ 95%
)]ž:;0F
.!"fg¢«%i^:67]MOP)*á³Z[BÜ_`>¶·_N!"¢«%>]ž
œ0•+E>=êN,a_bêŒMFÓY3linñc&d2(Beðfm}%«EV*
•;)ÙÚ¿'«~()(?g®hi±‡BSelective Estrogen Receptor modulator:
SERMEVd0FSERM )3ystŒÿV'«~()(?g®>j/œ0_±Vd0Fn
ñc&d2()*OP-L@0!"f.¢«%>kl_*!"ÔÕ>?@A•+Yd0O
4
P-y_N)"`f¢«%>klœ0F'«~()(+ʈ-nñc&d2()÷ÑaO
P-L@0Vm'$Ý>n@*o¡‡p>qrœ0F_Ž_*'«~()(+9Œ7*SERM
)!o§¨Y"§¨á>sƒÁ”*¡¦tuL6ŠøvBøvxwE"¢«%>$Ý:Á
0ЋPid0F
I Ò+•ÿYOPYÂÃ*v-¿à(ñáâdx€L6Š!oÞß.i!"YG-gþ>
|³œ0Aà-;·Vd0FéêN*Ó—ÓâY!o>6S½uNLSy/Vd0F z{
-gh;AÂÃ*!oYÓ||.-6uNÓâY!o-L@0_•7Y;}>{=œ0•
+)* ;·Vd0+=êU;0F!_MÖ×-‹MN)*Ô#Ü-x~:;AMF
STAR B1
1999 C 5 D-·¶uAnñc&d2(L6Šâ(c&d2(B1BThe Study of
Tamoxifen and Raloxifene (STAR) trialE)*!"¢«%]žB1Vd0FSTAR B1) 2
‹Y SERM*‹¶7nñc&d2(+â(c&d2(B'•«nE-‹MN*35
>çê
A!"f.¢«%Y]M÷ÑaOP-L@0!"f.¢«%kl€•>€‚œ0B1Vd
0FB1)*JKKi"jkÌBNational Cancer Institute: NCIEL6Š!"L6ŠÝƒ
"Yåa7ná³Õî-‹MNYkK„(12%~BNational Surgical Adjuvant Breast
and Bowel Project: NSABPE-6uN•…:;AF†‡B1m€n-yœ0QqY¤ˆŽ
U*nñc&d2(L6Šâ(c&d2()M”;,*!"¢«%Y]MOP-L@0Æ
ÇP!"¢«%>µ 50%]žœ0•+iC:;NL7B•;)xy¢«%Vd0F•;U
_±>‰·_NM0OP-L@0!"¢«%>]žœ0Šy¢«%) 2%(3%Vd0E*
M”;Y_±,.†Y‡>‹Û-ŒŒh•+)ŒMF•;U_±-6uNfÖœ0•Ž·
)9Œ0Aà*Ó;«;Y_±Y¢«%Bö÷PE+•|dx}~Bû•E-‹MNÔ#
Ü+@_Ãh•+F
|.‘– ’â– (
JKZ[ÜÕ•€•«ÚÛŽ“y5BU.S. Preventive Service Task Force: USPSTFE)*
40(75
YOP-y_N 1(2 C- 1 ”à(ñáâdx€>?@0•+>çè_NL7*
JK"³5BAmerican Cancer Society: ACSE)›CYà(ñáâdx€>çè_NM0F
à(ñáâdx€)Üói!"Y«%¢€•(á-·M0y/Q?Yä„Vd7*ß.V
T‹@0-)„:œ•0ØÙ,|³V/0FkNYOPià(ñáâdx€-‹MNÜó
-x~_*ý挫%¢€•(á«–1—€ð>iN0y/Vd0F
E-*à(ñáâdx€V,"iò˜+:;0•+id0F癚M›œæ•²žî
BMRIEŒÿYûY!oŸžî)*«%¢€•(ác¿VYð€
(¶·igh;NMŒ
MF_Ž_*Ó;U)*BRCA øù¼9Yd0OPL6Šï1c(¢(£ØÔÕVëìí
úì>?@AOPŒÿ*!"¢«%Y]MOPY¡¢-;·Vd0+-h;0F•;UY
ûY«%¢€•(áèî)*|.V£h_MÌòi³AÂÃ-,·M0•+iV/0F|
5
.V£h_MÌòi¨U;AÂÃ*à(ñáâdx€Vz:+¤¥:;NMN,*!_M
|9>?@0¦Hid0F
I USPSTE L6Š ACS V*!oÞß.-yœ0çèxgi9Œ0FUSPSTE )!oYÞ
ß.>à(ñáâdx€+ÊE-gh•+>çè_NL7*ACS ) 1(3 C- 1 ”Y!oÞ
ß.>çè_NM0F!oYÓ||.-60!"[\{Y™R)C:;NMŒMi*OP
iÓ—Y!o-‹MN3½_*!o-¼ái.ËAÂÃ*ÓY•+-œªS•+)•HV
d0FOP)*¤Ð*pÔÜ+«%¢€•(áY\'-‹MN@_ÃuNMA–/AMF
gþ
I !"YOP-)*aYgþiÖ;0+-h;0FM”;Ygþ,C:ŒM!"YOP,
M0Fd0M)*•;UYgþ)*"}½Y•~-6uNÐ/Ñ•:;0•+,d0F•
•-d"U;Agþio¥:;0ÂÃ*Ô#Ü-x~œ0•+F
I _Ž_*!"if._AOPYÒ+•ÿV**¦Mgþ)Ö;NMŒMF•Μy/*
¦L6Šgþ)*aY6hŒ,YVd0F
.lAŒ_•7BOPYRSV*^:!o)RŸ§S¨‹¨‹_NM0E¶A)!o¶A
)PYRYD©
.!•Yª«*—¬±¶A)⮿¼áB!•Y-®¶A)¯¢¯¢œ0‰@¿Œ«TE
.WXY°±*¶A)¼á*lê†O–*SÍT*²þ*l_M_hŒÿ
.³´(1YW-µAW¶B·WþWX+…†;0E>6h!oY¸>¹ŠA)Mº»
.!oxyY«TB!"YgþVŒMÂÃiRMi*Üó-×®œ0y/Vd0E
./
I Üó)RSY|9>·MN">./_*KIY;}>¼vœ0F3yY|9V)*Q,
€•¿+=êU;0ÔÕî,—Ž0FÒ+•ÿYn–„Y"V*.|BŸOYst>c³
_*½¾¿ôõœ0Ei*"Y{v./>RœAàYÀ3YèîVd0F.|iV/ŒM
ÂÃ*./-Ái‹ãŒ|9iÜóŽUÂÃ:;0•+id0FÄž|9)*"YKIY
;}>|Åœ0E-¶·:;0F./|9>ÙÚœ0+/*Üó)aY•+>=Æœ0Š
‹Pid0F
.CÅL6ŠkâYÇÈþ;
."Y4É
.gþY•g'
.•;¶VY|9R•
I ^:*!"Y./)*OP¶A)Üói«%¢€•(áYà(ñáâdx€V_•7¶
A)9:ŒÊËáB^: X íãäV|³:;0„:Œþð&ÿ-YÌFE>fò*d0M
)Þß.¶A)Ó||.V!o-9:>fòœ0+•¤ŽU·¶0F!"Y./>{=œ
0Aà*MS‹ŽY|9i·MU;0+-h;0F¦”_,k4i*•;UY|9kN>
6
?@0h@V)ŒMF
I «%¢€•(áà(ñáâdx€-éê*aY|9,!"./-¶·:;0+=êU;
0F
Äž|9
./¿à (ñá âdx €F./¿à(ñáâdx€)«%¢€•(áà(ñáâdx€+
ÒÍÊËVd0i*ŸÊ:;0!oãäYÍÞiRS*!•—¬±¶A)l_M_•7+
MuAgþ>fÖ_NM0OPVgh;0•+iRMF./¿à(ñáâdx€)*«%
¢€•(áà(ñáâdx€V£h_"ŒÌòi|³:;AÂÃ-,·MU;0F
ç™ šF 癚|9V)]¿šÞ™š>û·_N*!ostYÄžiŽw:;0F癚
|9V)*u:Y_•7B"YÂÃid0E+¦®inA:;AΨB^:*"VŒME
+iÏã:;0F
MR IFMRI V)*X íV)ŒS›Â>û·_N*â®Y!§ŒÄžiŽw:;0F"+.
/:;AOP-LMN*±yÈY!oVY"Y;}>{=œ0Aà- MRI i¶·:;0i*
•Y;•P-‹MN)*ÐÑYd0+•¤Vd0F«%¢€•(á-,¶·:;0FJK
"³5BACSE)*!"¢«%Y]MOPBlê† BRCA 78øøù¼9Yd0OP¶A
)¢M!"ÆÇÈ>‰‹OPE-)à(ñáâdx€+ÊE- MRI «%¢€•(á>gh
y/–+_NM0F¹-!ostm'iÒàN]MOPŒÿ-LMN*!oxY„:Œ?
>ôõœ0-)*MRI Yèià(ñáâdx€M癚67,Ó;NM0ÂÃiRMi*
£’PB"iz×_ŒMY-*|9R•ŽU"i£h;0•+EY|9R•iC:;0{
{i]S*.|Y”Þi$éœ0•+-Œ0FéêN*MRI V)*ÐÆÇP!">Cœ+
-h;0ÊËáiÛUŽ-ŒUŒMF!_MÖ×-‹MN)*Üó-x~œ0>LÔàœ
0F
½Õ¿| 9
.| F ûY|9V,*"izל0•+)½UÁNS;0i*{v./>RÁ0Y).|
–@Vd0F.|Vc³_A•(„ð)*»ëÜB†‡|9Y¤¥>ÚÛ+_*§¨*s
tL6ŠÖ×>ôõ_N»œY./>ghÜóE-6uN|Å:;0F
.Äž‘–’-60.|)*Û{-_•7iß½:;ŒMÂÃ-·MU;0F•YÂÃ*
ذÙÐ.|Bfine needle aspiration biopsy: FNAB*§MÚ>·MNst•(„ð>c³
œ0E*všÚ.|BX í>·MN*c³œ0stÛÜ>|³œ0E¶A)ÙÐØ.|BE
àYÚ>·MN*Ý/MstY˜oy—>RÞc³œ0Eigh;0F à(ñáâdx€*
癚¶A) MRI -6uN*•Y|9˜*Ú)£oÛÜ-‘–’:;0F•(„ðstŽ
U"Vd0•+i\Û:;*:U-äåi¦HVd0ÂÃYAà-*.|yš>à€%œ
0Y-*„:ŒÝ‚Þ%¢}„>ßàœ0•+,d0F•YäîYûF)*1 ”VÔÕ¶A
)«¬€1¡¢iV/0Š‹Pid0•+Vd0F
.ß½_h0_•7ŽUÚ.|-6uNsti*FNAB -6uN§¨iá‘:;*WP§
7
¨Y;}>|ÅV/0F
.½Õ¿.|-6uNQ,Ý/MstOic³:;0F½Õ¿.|V)æDB_•7Y3
yic³E¶A)æZB_•7k®ic³Eigh;0F
"+./:;AU*Õ—ŒæZ/âBØÙ¿ÀY"§¨iz×_ŒMstÛÜE>¨0
Aà-*d0M)¢(£´>Z6œ0Aà*2 'cYäåi¦H-Œ0ÂÃid0F
I .|st>·MN*ÔÕèÚYãv-Ái‹|9>ghÂÃ,d0FÓY|9+)*R
ºY6hŒ,YVd0F
.ØÙY¹*F½¾¿R-ØÙ>ôõ_*ÆÇPŽÐÆÇPŽ*!‡"Ž„{"Ž*á´
€’B§¨YL'E)M”;ŽB"§¨iÇÈŒ§¨+ÿYL'9ŒuNM0ŽE*"i
¡‡¶A)¢(£‡-¾iuNM0ŽäŽ>òÒà0F
. ' « ~ ( ) ( ? g ® B Estrogen Receptor: ER E L 6 Š „ ( ) « ¬ ( ( ? g ®
BProgesterone Receptor: PRE|9F•;UY?g®>fÖœ0!"§¨Y$%)*'«
~()(L6Š„()«¬((-”zœ0F•;U?g®Y;})*~•YZaB”åY
òæTEL6Ч¨iïðñ(Õî-±ç_MœMŽäŽ>¼/œ0WVÁi‹F3è¿
-*ER ’P¶A) PR ’PØÙ)ïðñ(ÔÕ-±çœ0F
.HER2/neu |9F!"Yµ 25%V)*HER2 é܇iÒê-zל0FHER2 Yþ;)*
~â«ë—àìBí€$„
(E+…†;0_±i!"YÔÕ-;·ŽäŽ>¼vœ0W
VÁi‹F!§)*ASC O ~ •‘– ’å! "-L @0 HER 2 | 9>3À:;AMF
.ØÙY78¿<ÛFOP!"Y!§>뤜0Aà*ØÙY.±³¿Èî>Äy0|9
i3è¿-Œ7‹‹d0FOncotype DX )*^:V)ïðñ(Õîigh;0+=êU;
0«¬€1 I ¶A)«¬€1 II Y¢(£´˜P*ER ’P!"OP~•-L@0 10 CaY
XY`fB!o}½YÂÌ-L@0"Y
7b_EY¢«%>¯vœ0AàY|9Y34
Vd0F•YÖ×)*ÔÕtÄ>iN0WV,;·Vd0+=êU;0F!§)Ô#Üx~:;AMF
¡¦|9
I Üó)*"-‹MN!_S½0Aà*¡¦|9>ïà0ÂÃ,d0F
k¡ðt ñBC om p le te Blo o d C oun t: CB CE FCBC )*}R>¯vœ0Aà-•…
:;0¡¦|9Vd0F
.òñá(•(ŒB)¡ð˜Yó“OE
.òà~%¢}~ŒBk¡˜-ßà0)¡ðY>ÃE
.Ü¡ðÞB*+g+ôh§¨E
.¡„õÞB¦HŒ+/-¡¦>tu:Á0AàY§¨E
.—ÄBÞ4ÉYÜ¡ðÓ;«;ißà0>ÃE
öðþ¢ ï«d ÷n€ øF•Yù“G'i]MÂÃ*»¼iZ[*V¶A)ú‡-¾iu
NM0•+iC:;0+=êU;0F
8
û • ¢ ð • ( Œ * ¡ ü á ð n ý ( ó ³ c þ ( ÿ ó ~ â ( « ö ý ! € ø B SG OT E Œ
L6Š ¡üá ðný (ó "ð• (ó~ â( «ö ý!€ øBS G P TEŒ F•;UY|9
-6uNZ#‹i¡¢:;0F•;U|9ŒYM”;Ži]ŒYÂÃ*ZKIYŠ‹PY
&á!ðVd0Z$%i=êU;0F
ØÙà€ þ€| 9FØÙà€þ€B¡üà€þ€¶A)f–³à€þ€+,…†;0E)
~•Y¡¦*&¶A)st˜V|³:;0±‡Vd0FØÙà€þ€izל0ÂÃ*d
0M)ØÙà€þ€YŒiz:Œ67]M¶A)™MÂÃ*®xV9:ŒÒLiƒg_N
M0•+iC:;*Ó;)"¶A)"}½Y•~i]^–+=êU;0FØÙà€þ€)
./*ÔÕtÄMÔÕñ•n¢(á-;·Vd0+=êU;0F!_S)*ASCO ~•‘
–’å!"-L@0ØÙà€þ€>3À:;AMB'(iV/að*lAŒ¢(%iéê
U;0¶V)*ÖgY¢(%>û·>LÔàœ0EF
)é|9
I Üó)*"Y»->|Åœ0Aà*)é|9>*Cœ0ÂÃid0B<AY~•Y»È
L6Š.õR•-©ªSEF!§)*»-—ÉY$%&'(>3À:;AMF•;UY|
9ikNY~•-ÔàU;0+Mh•+)ŒMF
.dy X íãä>·MN*!oŽU`-¾iuA">+œÂÃid0F
.V«c,(>·MN*VKI>+œÂÃid0FV«c,(V)*ëìP~´€•€i
-.•ì:;*~´€•€)VÛÜ-2/_*«c,!€V|³:;0F
.0("—€n€~ñáâdx€BCT ¶A) CATE>·MN*XYKI_AØÙ>+œ
ÂÃid0FCT «c,(V)*RÞY9Œ01'ŽUŸÊ_A3&Y X íãä>·MN*
®xY 3 a2ÄžiŽU;0F0("—€n€-6uN*•;UYÄžŽU!§Œ3/î
ži12:;0F
.’4øëì/5ŸÊBPETE«c,(>·MN*"i¾iuAŽäŽ>¼vœ0ÂÃi
d0FPET «c,(V)*ëì†P>;œ06—ø>®x-•àœ0F"§¨)z:§¨
67&S6>Ù7œ0Aà*") PET «c,(WV8SFPET «c,() CT «c,(*
MRI L6Š|.V2àAÖ×>7Fœ0Aà-¶·:;0•+iRMF
•Y$%&'(V¶·_A·¸-‹MN)*PLWC ¹2º»å½uNLSy/"·¸å
l9./>3À:;0•+>LÔàœ0F
I 3è¿./|9-LMNZ¯:;0•+>!_S½7AMè)*PLWCå|9L6Š:
›>3À:;0•+>LÔàœ0F
»-—É
I »-—É)"><Ûœ0AàY3‹YèîV*lê†*ÿ•-š›œ0Ž*KIY;}
¶A)ÓYyš*ûY[ÖY#‹-ÊË>ÌÍ_NM0ŽäŽŒÿ>±²œ0FÜó)*
./|9>·MN"Y»->ãvœ0FÓYAà*»-—É)*kNY|9i2;œ0¶
V)<;_ŒM+=êU;0F»->½uNM0+*Q?YÔÕî>Üóiãv_=SŒ
9
7*~•YZa>çv_MœSŒ0F"Y4Éi9Œ;†*»-<Û,9ŒuNS0F
I Üói»-><Ûœ0Aà-·M0ä„Y3‹i TNM &«¬-Vd0F•Y&«¬-V
)"Y»->¼vœ0Aà- 3 ‹Y©'i·MU;0F‹¶7*ØÙÓY,Y*ØÙ¿À
Y¢(£´*ØÙiûYyš-¾iuNM0ŽäŽVd0F•;UYR•>ÃhÁN*~
•›-"Y»->ãvœ0F»-) 5 „…V*«¬€1 0 +«¬€1 I(IV Vd0F»-6uN*"><Ûœ0AàYæ^Yèîi¨U;*Üó)Q?YÔÕ>tÄœ0AàæÊŽ“>gh•+iV/0F
I TNM )ØÙBtumor*TE*R´Bnode*NEL6ŠKIBmetastasis*MEY>¸V
d0FÜó)•;U 3 ‹YH“>ÄyN*"Y»->ãvœ0F
.]fØÙYÝ/:L6ŠÓYš›Btumor*TE
.¢(£´•YØÙYKIY;}Bnode*NE
.ûYyš•Y"KIY;}Bmetastasis*ME
ØÙFTNM &«¬->·M0E*ÉTÍ+?@¶A)Þ@B0(4E>·MN*ØÙYÝ/
:+š›>AœF3yY«¬€1)*~•Yþ;>67!§-<ÛV/06h*„9BŒ
RšC-—>:;NM0F
TX å]fØÙ>¡¢V/ŒMF
T 0å !ox-"Y*¦i=àU;ŒMF
Ti såin situ*‹¶7ÐÆÇP"Y•+Vd0F•YÂÃ*")!ostYÓùYDExw_:;NL7*!oY¿=st•)¾iuNMŒMFÐÆÇP!"-) 3 4Éid0F
Ti sB DCI SE å ÐÆÇP!‡"BDCISE)*F-!"YfGþ;V*ŸÞY"§¨–@
i!‡ŽU|³:;*"i·¶uAstY5>HêN¾iuN)MŒMFa-ÆÇPY!
"-Œ7h0F
Ti sB LC I SE å ÐÆÇP„{"BLCISE)*!oY„{¶A)!zV9:§¨i|³:
;A•+>AœFLCIS )"V)ŒMi*ÄÅP!">fgœ0¢«%i]SŒ0F
Ti sB0€ 12} ~»Eå!•Y0€12}~»)*jŒ:YF-!"Vd0F0€12
}~»}½YØÙiz×_ŒMÂÃ-w7*•Y./i·MU;0FØÙid0ÂÃ*Ø
ÙYÝ/:-IuN—É:;0F
T 1å !oxØÙYQÝJi 2 cm }R
T 1m icå ¾„ÆÇ¶A)¾„KI#+)*ŸÞY"§¨i¿=st-¾iuNM0i*Ý
/:) 0.1cm }RVd0•+>ÎÏœ0F
T 1aå ØÙi 0.1cm ç*0.5cm mn
T 1bå ØÙi 0.5cm ç*1cm mn
T 1cå ØÙi 1cm ç*2cm }R
T 2å ØÙi 2cm ç*5cm }R
T 3å ØÙi 5cm ç
T 4å ØÙidK¶A)WX-¾iuNM0*d0M)#gP!"+./:;NM0F
10
T 4aå ØÙidKx-¾iuNM0F
T 4bå LØBØ;di7E*WXYD©B·WþWXE¶A)!oWXYMÙB!oWX
NstiO;*¯¢¯¢«ƒÂÌE*¶A)Ê3!oY¿=WXR´id0F
T 4cåT4a + T4b YïèY*¦iTU;0F
T 4då #gP!"F!oi)Sº;Wi7*¸>‰‹P&ƒg9Y!"Vd0F
¢(£´FTMN »-—ÉYÉNÍ)¢(£´Y•+V*•;)*+g+YôM>n@0„
:ŒQY:>_AÖ×Vd0FPYR*UVYWRL6ŠdVYR-š›œ0¢(£´)
Ì‚¢(£´+…†;0FûYyš-š›œ0¢(£´)Xš¢(£´+…†;0F
NXå ¢(£´Y¡¢iV/ŒMF
N0å¢(£´V"i|³:;ŒMF
N1å 1(3 <YPQ¢(£´-"iKI_NM0F
N2åPYRY¢(£´ 4(9 <-KI*¶A)PQ¢(£´KI>6hŒMxd¢(£´
BÊÈddVRSY¢(£´EKIid0F
N2aå"iPYRY 4(9 <Y¢(£´-KI_NM0BŸŒS+, 1 <YØÙ) 2mm >
çê0EF
N2bå")xd¢(£´YT•KI_NM0F
N3åPYRY¢(£´ 10 <}W•YKI*UVR¢(£´BUVYR-š›œ0EKI*
¶A)PQ¢(£´KI>6hx!o¢(£´KIF
N3aå"iPYRY¢(£´ 10 <}W¶A)UVR¢(£´-KI_NM0F
N3bå"ixd¢(£´L6ŠPQ¢(£´-KI_NM0F
N3c å"iUVW¢(£´-KI_NM0F
¢(£´-"KIid0ÂÃ*ÓY6hŒ¢(£´iQ<d0Ž>½0•+)*Üói
ÔÕtÄ>iN0WVÁ-i‹F»ëÜ)"iKI_A¢(£´YÞ>¯vV/0F
XYKI FTNM &«¬-YÉMÍ)*"iûYy—-KI_AŽäŽ>CœF
MX åXYKI>¡¢V/ŒMF
M 0å KI_NMŒMF
M 1å ûYy—•YKIid0F
"Y»- —É
I T*N L6Š M —É>sTÃhÁ0•+-6uN*"Y»-i*v:;0F
ð 0 -åÐÆÇ !‡")*!oY!‡¶A)„{BÓùYDEE>HêN¾iuNMŒM
"Vd0FÐÆÇP"+,…†;0F
ð I -å ØÙ)„:S*¢(£´-KI_NMŒMBT1,N0,M0EF
ð II a - åRºYM”;ŽO+‹-x#œ0ÂÃF
.ØÙ YÝ /:i 2cm } RV *PY RY PQ ¢(£ ´- KI _N M0B T1 ¶A )
11
T1mic,N1,M0E
.ØÙYÝ/:i 2cm ç*5cm }RV*PQ¢(£´-KI_NMŒMBT2,N0,M0E
.!ox-ØÙ>=àŒMi*PQ¢(£´-">=à0BT0,N1,M0EF
ð II b - åRºYM”;ŽO+‹F
.ØÙYÝ/:i 2cm ç*5cm }RV*PQ¢(£´-KI_NM0BT2,N1,M0EF
.ØÙYÝ/:) 5cm çVd0i*PQ¢(£´-KI_NMŒMBT3,N0,M0EF
ð II Ia -å RºYM”;ŽO+‹F
.ØÙYÝ/:i 5cm mnV*PQ¢(£´-KI_NM0BT1,N2,M0 ¶A) T2,N2,M0EF
.ØÙYÝ/:i 5cm çV*PQ¢(£´-KI_NM0BT3,N1,M0 ¶A) T3,N2,M0EF
ð II Ib -åØÙidK-KI_NM0*¶A)!oYØT¶A)MÙ>Ð/Ñ•_NM0*
¶A)#gP!"+./:;NM0B¢(%>éê0EFh/YRY¢(£´-KI_N
M0ÂÃ,d;†*KI_NMŒMÂÃ,d0i*ûYy—-)KI_NMŒMBT4,N0,M0*
T4,N1,M0 ¶A) T4,N2,M0EF
ð I II c -å ØÙBÝ/:)UhŒMEYXYKI)ŒMi*N3 CY¢(£´-KI_N
M0BT(M”;V,),N3,M0EF
ð IV -å ØÙBÝ/:)UhŒMEYXYKIi.Ë*KIyš)V*`¶A)Zd0
M)dKYÂÃiRMBT(M”;V,),N(M”;V,),M1EF
JK"ÃÊ345BAmerican Joint Committee on Cancer: AJCCEB–¢e–V&þWE
YXŠ>¨N¶·FYZ[Y2AYÖ×\)*AJCC "»-—Éà•—öðð 6 ´(2002)*
Springer-Verlag ³´B•—€]€%V*www.springer-ny.comEF
ÔÕ
I !"YÔÕ)ØÙYÝ/:+š›*KIY;}L6Š~•Ykè¿ÇÈþ;-”zœ0F
RSYÂÃ*Üó
€-)~•+^J_NQ?YÔÕtÄ>iN0F
I Üói*<AY~•-‹MN!"ÔÕtÄ>iN0+_N,*!"ÔÕ-)MS‹ŽY
3迌„…id0F¶”*F-Y»¼-yœ0G-ÔÕYc¿)* ØÙ¿À-i•§¨
YŒMy—>‹@NØÙ>‘7ZS•+Vd0F5ê-*Üó)ØÙ>c³œ0Aà-ä
å>Ôà0+-h;0FAMNMYÂÃ*Tz!ost-y_N*ëìíÔÕiÔàU;
0FëìíÔÕigh;”*ïðñ(Õîi‘uN_huA7*d0M)Œ•YÔÕ,g
h;ŒM¹`ŒÂÃ,d0Blê†*ã-•݌ܳ¿Uaid0~•ŒÿEF
I F-!"‡ë-L@0aY„…)*`f¢«%>kl_*"§¨iTuNM0ÂÃ)Ó
;>‘7ZS•+Vd0FØÙiÝ/MÂÃ*¶A)¢(£´KIid0ÂÃ*Üó)ë
ìíÔÕ*á³ÕîMïðñ(Õî+MuAÔÕY)é>çèœ0F`f"YÔÕ-)ˆA
ŒM7èid0F
I !"ÔÕtÄ>iN0ÂÃ*Üó)aY6hŒRÞYH“>=ê0+-h;0F
.ØÙY»-L6Šá´€’
12
.ØÙYïðñ(?g®Yþ;BER*PREL6Š HER2/neu Yþ;B./>ùúE
.~•YCÅL6ŠkâYÇÈþ;
.քY;}
.ú-½U;NM0!"78øøù¼9Y;}
I !"Y.±³¿Ìò)*ÓYP‡L6ŠÔÕ-ÊË>ÌÍœF„:Mi$%&'Y&M
ØÙid;†*Ý/S,$%&'YbMØÙ,d0F
äå
I 3è¿-*ØÙYÝ/:i„:@;†„:MÒÿ*~•-AêU;0äåÙÚc)$ê
0FäåY4É)}RY6hŒ,YVd0F
.!zØdc³åV)*ØÙL6ŠØÙ¿ÀY„:S*%¢öŒB">‚¶ŒME¿=s
ti‘7ZŽ;0FDCIS L6ŠÆÇP"YÂÃ*~y-)MźYëìíÔÕigh;0
•+iRMF!zØdc³å)y—!oæZå+…†;0ÂÃ,d0F
.k!oæZåV)*!ok®i‘7ZŽ;0i*PYRY¢(£´)æZ:;ŒMF•
Yäå)ef!oæZå+,…†;0F
.Ðv9gÔ¿!oæZåV)*!o+PRY¢(£´i‘7ZŽ;0F
.PQ¢(£´æZV)*PYRŽU¢(£´>c³_*»ëÜi"§¨Y;}>|9œ
0FæZ:;0¢(£´Y•¬YÞ)¶º¶º–+-h;0F
.$(
|ð¢(£´.|+)*!oŽUY²¦>?@0$(
|ðBò»7Y*QGYE
¢(£´B^: 1(3 <Y¢(£´E>½ÕÜiò‹@–_*c³œ0•+Vd0FÓYa*
»ëÜi"§¨Y;}>|9œ0F$(
|ð¢(£´>ò‹@0Aà*½ÕÜ)!•¿
=-h“MëìP~´€•€>•àœ0Fh“¶A)~´€•€)¢(£´-IJ_*¶
”*$(
|ð¢(£´-iœœ0FÜó)*hi¼áBh“i¶·:;AÂÃE¶A)
ëìíB~´€•€i¶·:;AÂÃE>f_A+•¤V*$(
/0F$(
|ð¢(£´>|³V
|ð¢(£´.|)*PQ¢(£´æZ67,¢(£LØBjYØTEY¢
«%i™MÂÃiRMF$(
|ð¢(£´ŽU"i|³:;ŒMÂÃ*aY¢(£´-
,"iŒM{{i]M+Yjkm€niC:;NL7*Ó;}WY¢(£´äå)gh;
ŒMF$(
|ð¢(£´ŽU"Yz×iC:;AÂÃ*½ÕÜ)PQ¢(£´æZ>g
h+=êU;0F!§)*ASCO ~•‘–’åF-!"-L@0$(
|ð¢(£´.|
>ù=-:;0•+>LÔàœ0F
.!oæZå>ghOP)*!o`kåB!o>`kœ0äåE>=ê0•+>lƒ+h;0F`k-)â®YãŒy—Yst*¶A)um!oi·MU;0F`k)*!oæ
Zå+ÊE-gh•+,V/0_*aM*ÿ•ŽYEFVgh•+,V/0F
I ÆÇP"~•YÒ+•ÿV*$(
0F$(
|ð¢(£´.|¶A)PQ¢(£´æZigh;
|ð¢(£´ŽU"iC:;AÂÃ*PQ¢(£´æZ)Ö×YÌ*¶–¦H
Vd0+=êU;0F•Y•+-‹MNYjk)Ð/@/|Å:;NM0F
13
I Hµœ0+*äåÙÚc)aY6h-Œ0F
.!zØdc³å¶A)y—!oæZå+ëìíÔÕ
.3yVÊE`k>6M*$(
|ð¢(£´L6ŠPQ¢(£´æZ>3yn·œ0k
!oæZå
.3y-ÊE`k>6hÐv9gÔ¿!oæZå
Ä Å P ! " Y Â Ã * ! z Ø dc ³ å ¶ A ) y —! o æ Z å + ë ì í Ô Õ Y n· Y ;
€Pi¼ :gÔ ¿!o æZå +Êñ Vd0 •+ i*†‡ B1Ž U\Û :;N M0F
I ~•)*M”;YäåÙÚciÓ—-ý_NM0Ž-‹MN*¤ÐÔ#Ü+x~:;A
MFÄÅY]MäåB!oæZåŒÿEi¦”_,oM+)wU”*ãŒÃngi.Ë0
+Mh•+,=êU;0F
I !_MÖ×-‹MN)*PLWC ¹2º»å!oæZåa*PLWC ¹2º»å!o`kL
6Š PLWC ¹2º»åum!oYÙÚ>3À:;AMF
7nÕî
I 7nÕî+)*!"i`fœ0¢«%>žUœAà*äå-)é_Ngh;0ÔÕVd
0F7nÕî-)*ëìíÕî*á³Õî*ïðñ(ÕîL6Šp¿ÕîŒÿid0FM
”;,ÓYc¿)*G”ÔÕa-Tzœ0!"§¨>Z6œ0•+Vd0F7nÕî-6
uN`f¢«%)™Rœ0i*¦”_,ŒSŒ0h@V)ŒMF
I »-—É-éê*ûYqrŒä„>·MNZa>çvœ0•+iV/*dŒA+Ô#Ü
i7nÕî-‹MNã/œ0WVÁ-i‹Fÿ'ì•–~Yö1—f(~s³(â–(
Bwww.adjuvantonline.comE)ÓY6hŒä„Y3‹V*Ô#Ü)••-ö%$«_N*
ˆAŒZa-£&œ0^øY¤¥>gh•+iV/0F•Yÿ'ì•–~)*Ô#Üi¤
¥œ0ÂÃ-w7¶·œ0•+F
ëìíÕ î
I ëìíÕîV)*]'|ðt€X í¶A)ûYuø>·MN*"§¨>[v:Á0Fëì
íÕî)*ØÙyšpq¶A)!oxYM”;Ž-zל0Tz"§¨>Z6œ0Aà*
^:!zØdc³å¶A)y—!oæZåaÞw,-hA7•…:;0FëìíÕî)!
oæZåaYOP-y_N,*ØÙYÝ/:*PRY"KI¢(£´YÞ*äåVc³:
;AØÙ¿ÀYst/âYx-”z_N*ÔàU;0ÂÃid0FëìíÕî)*Ý9Y
ØÙ>7y:Á*c³_MœSœ0Aà*åf-…g:;0ÂÃ,d0F_Ž_*•Y6
hŒ‘7sT)jVd0F
I ëìíÕî)*!oL6ŠdKYïè-LMN*!"`f{>klœ0WV;€Vd0F
Q,6Sgh;0ëìíÕî)*ëìí½yúì+…†;0,YVd7*•YÂÃ*®½
Y#zŽUëìíiúì:;0F®x-{àæ•VëìíÔÕ>ghÂÃ>xyúìÕî
¶A)„í\Õî+…
F:U-*ëìíÔÕ>ghfð€(þ¬€¬ð,d0Bà(ñ
14
•–~+…†;0EF
I !zØdc³å¶A)y—!oæZåaYp'¿ëìíÔÕ+_N*5 M,BD(Ý|ME
Y½yúìi 6(7 w,gh;N/AF^:)*QGY 4.5(5 w,-!ok®•Yëìí
úì>gM*ÓYa*T7YÔÕ-,*!oxYØÙž}BØÙiduAy—E-~F>
#NAúìigh;0F!oæZåaYp'¿ëìíÔÕ)*dK- 5 M,BD(Ý|ME*
5(6 w,-hAuNgh;0FPR¢(£´ŽU"i=àU;AÂÃ*!o¶A)dKq
SYSy¶A)PRy—Y¢(£´ÛÜ-,ëìíÔÕigh;0+=êU;0F
I ëìíÔÕY-,> 6(7 w,ŽU 3(4 w,¶A) 1 w,L'¶V•yœ0l_Múì
î-yœ0£oi]¶uNM0F6Sgh;0èî) 2 ‹d0F
.3‹)*1 MdA7YúìíO>$M_N*!ok®-›Múì_*k迌ÔÕ-,>
3(4 w,-•yœ0+MhèîVd0F!ok®•YëìíÔÕ…g˜¶A)…ga-*
!oYØÙž}•Y]íOúì>n·œ0•+,V/0Fþ!€L6Š•KVY†‡B1
ŽU*•;UY•y«–1—€ði,-úì«–1—€ð+ñ_S~•-?@à;U;*
"0(~(€ð{L6Е޷,¼hUŒM•+iC:;NM0FÖ×*JKV)*F!"Y3y~•-,•Y•y«–1—€ðiý·-Œ0+=êU;NM0F
.,h3‹)*y—!oúìBpartial breast irradiation: PBIE+…†;0èîV*ëìí
iØÙž}–@-úì:;*"i=àU;ŒM!oYûYy—-)úì:;ŒMFëìí
ÔÕ) 1 M 2 ”*h”Ž 1 w,-hA7*½yúì*3E¿ëìíþ¬€¬ð¶A)!o
x{àæTþ¬€¬ð>·MNgh;0F•Y4YëìíÔÕiý·+Œ0~•)3ywU;0+-h;0FZ(B1ŽU);lŒR•iC:;NM0i*•Y‚å-‹MNY
Ý9BŒkK¿†‡B1igh;NL7*ƒkPL6Š;€P>p'¿ëìíÕî+€‚
_AR•)¶–¨U;NMŒMF
I ëìíÕî)*„…*ØTL6ŠWX¼á+MuA•Ž·>Ð/Ñ•œFëìíúì6uN`Y3yiÊË>?@0•+,d0i*`#¶A)ëìí£&`#Y¢«%)™MF
Ò6-LMN*†M‡›+‚å-67ëìíúìigh;AÂÃ*R!"-y_NÔÕ>
?@AOP-LMN*XY-Yo•~¢«%iˆŽ-$Ý_AFÖ_V)*l_M‚å6uNo[YÒ+•ÿYy—iëìí$%ŽU5U;0Fëìí‰P)*XY--L@0
f"Y¢«%+=êU;NM0i*úìÛÜ-!"V)ŒMãŒ">fgœ0~•)*.
zl 500 lYhº 1 lmnVd0F!zØdc³åŠëìíÔÕ+!oæZå>€‚œ0
†‡B1ŽU*20 C,-ãY">fg_A~•Þ¶A)ãŒ"-6uN[\_A~•Þa)C:;ŒŽuAF
I !_MÖ×-‹MN)*PLWC ¹2º»åëìíÕî>뤜0*PLWC ¹2º»åë
ìíÕYÑ1*PLWC ¹2º»åëìíÕîY•Ž·>3À:;AMF
á³Õî
I á³ÕîV)*_±>·MN"§¨>[v:Á0Fkâá³ÕîŒ)*kâY"§¨>
15
p¿+_N*¡•ŽUŽU;0Fá³ÕîY•Ž·)*~•<uL6ж·:;A·O”z_*lê†*„…**+¢«%*Wo.••*‘’É“L6ŠR”Œÿid0F•;
UY•Ž·)*3•ÔÕi2h;†*–^)—˜œ0F¶;-*•Ž·i,-áœ0ÂÃ
id7*lê†o[$%¶A)öa"Œÿi!"U;0i*MS‹ŽYjkŽU•;UY
•Ž·-6uN~•Y.z-,)•y:;ŒM•+iC:;NM0F
I á³Õî)*Ñ™šAB™ŽUE¶A)-•šAB-.-•ìE:;*^:)¿-¿šA:;0Fá³Õî)à›>¦H+_ŒM•+iRS*½œVšAigh;NM0Fá
³Õî)*|³ö1—f(~ÕîBÝ9YØÙ>7y:Á0Aà-äåf-gh;0EM
7nÕîB"`f¢«%>R"0Aà-äåa-gh;0E+_Ngh;0ÂÃ,d0F
!"`fE-,*á³Õîigh;0+=êU;0F†‡B1-ùé_A~•-)*l_
¶A)úz_±Yl_Mn·iÂB:;0ÂÃ,d0F
I "i9Œ;†;·Œ_±,9Œ7*MS‹ŽY_±>n·šAœ0èi*<ã-šAœ
067;€Vd0•+iB1ŽUC:;NM0F!"YÔÕ-)aY_±i¶·:;0+
-h;0F
.&%(ï«d÷ý’B•–~c•(*|³•€ðE
.•ž~´c$€~BRÞYŸp
id0E
.dð³(ÿâ&ðB5-FU*ö’ð&ðE
.’cžð•&(Bö’¢öà–&(*ð•}%«E
.0áᢡž€-9’cžð•&(BDOXIL*Dox-SL*'f$}~*LipoDoxE
.'"ð•&(B'´(«E
.£%¢nc$ðBncž€ðE
.’$nc$ðBncž¬€ðE
.•e´ð•(B!•ð•(E
.þ0&n•(Bø(€€E
.éÜRã%¢nc$ðBöìâc•(E
.)-&n•(B12-þ€ðE
aY6hŒn·i6S·MU;0F
.CMFB&%(ï«d÷ý’Š•ž~´c$€~Š5-FUE
.CAFB&%(ï«d÷ý’Š’cžð•&(Š5-FUE
.CEFB&%(ï«d÷ý’Š'"ð•&(Š5-FUE
.ECB'"ð•&(Š&%(ï«d÷ý’E
.ACB’cžð•&(Š&%(ï«d÷ý’E
.TACB’$nc$ðŠ’cžð•&(Š&%(ï«d÷ý’E
.AC*aMV TB’cžð•&(Š&%(ï«d÷ý’*aMV£%¢nc$ðE
.TCB’$nc$ðŠ&%(ï«d÷ý’E
.ATB’cžð•&(Š’$nc$ð*’cžð•&(Š£%¢nc$ðE
16
.GTB)-&n•(Š£%¢nc$ðE
.’$nc$ðŠþ0&n•(
I •;U_ŒY˜-)*p¿ÔÕ_Y~â«ë—àì+n·:;0,Y,d0BRºùúEF
I "ÔÕ-·MU;0_±Õî)*Ð/@/¡¢igh;NM0FÔ#Ü+@_Ãh•+
i*Ó—-:è:;NM0Ü_`*ÓYc¿*•Ž·Mx¢Ž·-‹MNYÖ×>½0A
àYQ?Yèî+Œ0ÂÃiRMFPLWC Y_±Ö×¢ž€«)*RÞY_±m€n•€
«•Y¢(%>ÂB_NS;0Aà*•;>·MN:è:;A_±-‹MNY½Ý>£à
0•+F
I
ïðñ( Õî
I ïðñ(Õî)*|9V'«~()(¶A)„()«¬((?g®i’P+C:;AØ
ÙYÔÕ-;€Vd0F•Yn–„YØÙ)*ïðñ(>·MN*$%>†f-œ0Fï
ðñ(>j/œ0•+-6uN*^:pHY$%ilw:;0F
I ØÙiïðñ(?g®’PB$%œ0Aà-'«~()(¶A)„()«¬((>¶·
œ0¤./>ùú¥EVd0•+i¼Û_AU*ïðñ(ÔÕ>e¦V*d0M)á³Õ
î+n·_N·M0•+iV/0Fnñc&d2(*ö!«~(§€ðBö¢ým}%«E*
´~(§€ðBd2à€âEL6Š'%$•«n(Bö(à&(EŒÿYïðñ(ÕîŒ
i7nÕî+_Ni¶·:;NM0F
I nñc&d2()*ïðñ(ÕîŒ+_NQ,,--hAuN|Å:;N/A_±Vd
0Fnñc&d2()*'«~()(Y!"§¨•YRÃ>j/œ0FÔÕigh;A!
o-L@0`f¢«%*±yÈY!o-L@0f"¢«%*!"Y»È)ŒMi*!"f
g¢«%i•Ž67]MOP-L@0f"¢«%>klœ0Aà-;€Vd0•+iC:
;NM0FÖ×Y+•¤*nñc&d2(> 5 C>çêN‰·œ0•+-60;•P)Œ
M•+iC:;NM0F
I nñc&d2(Y•Ž·)*¨î©ª*øvBøvxwE"L6Šøv«Ø¢«%Yˆ
ŽŒ$Ý*¡¦tu¢«%Y$ÝŒÿVd0Fnñc&d2()*÷ÑfL6Š÷Ña*
M”;YOP-y_N,;€Vd0F
I !"fg¢«%Y]M÷ÑaOP-LMN*â(c&d2()nñc&d2(+ÊñY
ÆÇP!"Z[€•>;œ0•+iC:;NM0i*DCIS ŒÿYÐÆÇP"-‹MN)*
Ó;ÒÿYZ[€•)ŒMFâ(c&d2(Y•Ž·)*¡¦tu¢«%YˆŽŒ$Ý*
¬L6Š£´«*¨î©ª*P-«*®¯°ŒÿVd0Fâ(c&d2()÷ÑfOPL@0|Åigh;NLU”*ïðñ(?g®’P!"OP~•-yœ07nÕîŒ+_
N*nñc&d2(Y_±_-Œ0+)=êU;NMŒMFâ(c&d2()ÆÇP!"
ÔÕ-)ÔàU;ŒMF
I ö(àn€ø²%Œ)÷ÑaOP-LMN*'«~()(>Ž0Aà-¦HŒö(àn
€øù“>j/œ0•+-67*'«~()(>žŸ:Á0F•;-)*ö!«~(§€
17
ð*´~(§€ðL6Š'%$•«n(Œÿid0Fö(àn€ø²%ŒY•Ž·)*£
´«L6ŠV³¢«%Y$ÝŒÿ–+-h;0F!_MÖ×-‹MN)*ASCO ~•YA
àY‚å¡¢åF-!"-yœ0ö(àn€ø²%Œ>3À:;AMF
p¿ÔÕ
I Þ4ÉY;lŒl9!"ÔÕ_)*§¨>´ä-$%.—>:Á09:Œé܇YŽ·
>µà0•+-6uNŽ·>f¶œ0F
I ñe%(€!ð·®)!"§¨˜-‹_SÝO-zל0é܇>p¿+_NM0F
.~â«ë—àì)*HER2/neu é܇>AS:•fÖ_NM0ØÙYÂÃYƒgP!"
ÔÕ_L6ŠF-!"Y7nÕîŒ+_N<=:;NM0F2005 CJK†‡ØÙ³5Ca
25-LMN*HER2 ’PF-!"OP~•-~â«ë—àì>7ná³Õî+ÊE-*
d0M)7ná³Õî2;a-šA_A+•¤*`f{iµ 50%kl:;*.z{iµ?
_A•+i×®:;AFÖEFV*~â«ë—àìY 1 C,šAiÔàU;0F~â«ë
—àìšA~•V)*o[-Uai.Ë0¢«%i 4%d7*û-o•~-yœ0ö÷^ø
>‰uNM0~•V)*•Y¢«%i:U-$Ýœ0F•;UYo[YUa)¦”_,Œ
SŒ0h@V)ŒMi*_±ÔÕiŠ‹ŒÂÃiRMFÿ;ÒÿY~â«ë—àìiÕ—
Ž>|Åœ0B1iƒg˜Vd0B9 w,(2 C,EF
.•f&—àìBöf«
(E)*Ö׆‡B1V|ŘY·¡‡:wPñe%(€!ð
·®Vd0F·¡‡l.Œ)*ØÙi$%.KIœ0Aà-¦HŒ¡‡l.Bl_M¡‡
Y:wE>j/œ0F!"iKI_AOP-LMN£%¢nc$ð+n·œ0+*•f&
—àì-6uN*£%¢nc$ðe¦YÂÃ67;€{i$Ý_*;€-,i¸,œ06
h--h;0F
.~â«ë—àì-±ç_ŒSŒuA HER2 ’P!"OP~•V)*â£
•ìBn–þ
€ìE+…†;0l9_Œi*þ0&n•(+Yn·-6uN*!"Y$%&'>LSU
Á0ÂÃid0Fâ£
•ì+þ0&n•(Yn·)*á³ÕîŒL6Š~â«ë—àì
>·MAÔÕÈ>;œ0ƒgP¶A)KIP HER2 ’P!"OP~•-yœ0ÔÕ_+_
N<=:;NM0F
`f!"
I !"iQG-./:;*ÔÕ>?@Aa-"i
7b_A+/*!"i`f_A+¹h
;0F`fœ0yš)*!oB_Ì`fE*dK¶A)XY[ÖB`*ZL6ŠVŒÿE
>‚ƒ®xYûYy—i=êU;0F
I !")*^*yÈ!o*•º*»[L6Š"#Œÿ*ûY[Ö-KIœ0ÂÃ,d0F
ØÙiKIPB!o¶A)_Ì¢(£´Y½È-¾i0EYÂÃ*3è¿-")Լɋ
Vd0Fƒg!"ÔÕYc¿)*½¤B3E¿¶A)¾@¿-»¼iŒME>Áwd0M
)ØÙ$%&'>b¸:Á0•+Vd0F3yY~•)*!"`fa*QC,,.z_*
18
RÞYˆAŒÔÕ>?@0ÂÃ,d0FF-fòèîL6Šl_MÔÕîY³Ö-6uN*
3yY~•-+uN!")¿P•~+òŒ:;0Ž,_;ŒMF
I 3è¿-*gþi³Ö_A+•¤V*`f)|³:;0FgþiV0œ0f-KIP`
f>ò‹@0|9iduA+_N,*|9-6uNƒgP»¼-·MU;0ÔÕ-yœ0
±çiµ?œ0h@V,*¸ÀV/0h@V,ŒM•+iC:;NM0F
I KIP»¼i|³:;AU*KI#c³äåigh;0ÂÃ,d;†*á³Õî*ïð
ñ(Õî*ëìíÕî¶A)p¿ÕîB~â«ë—àìŒÿE-6uN0(~(€ðœ0
ÂÃ,d0F*¦L6Šgþ)`fyš-”z_*RºY6hŒ,Yi‚¶;0F
.PR¶A)dK-ÁuA_•7
.V«¶A)V³*•;)VKIYf–+=êU;0F
.•«¶A)@M;•fŽ*•;)^KIYf–+=êU;0F
.¿PYÃĶA)…ÙÅÆ*•;)`KIYf–+=êU;0F
I û-,KI#Yš›-£&œ0gþid0+-h;*ÞJ¼á*†JY¼á*®ÄÉo*
Ò'Y„…Œÿi!"U;0+-h;0F
I ./>{Ç_*ER*PR L6Š HER2/neu Yþ;>Äy0Aà*`fyšY.|iÔà
U;0•+iRMF!zØdc³åL6ŠëìíÔÕ-60G-ÔÕYa-!ox-`f
_AOP-yœ0ÔÕ)*!oæZVd0FG-!oæZåYadK-`f_AOP-y
œ0ÔÕî)*dKL6Š¢(£´•YëìíÔÕVd0FŠ‹ŒÂÃ*ïðñ(Õîi
¶·:;0•+iRMFá³ÕîL6Šp¿ÔÕ,*3yYglV·MU;0FXYKI
`f!"OP~•-LMN*þÈ-6uN)ëìíÔÕL6Šäåi¶·:;0ÂÃ,d
0F
I !"YAàY ASCO ÔÕÃx-)*F-!"YAàYö(àn€ø²%Œ*!"YAà
Y•«ï«dÉ|€~*!"YÊ@ÔÕ*!"-L@0 HER2 |9*F-!"-yœ0$
(
|ð¢(£´.|L6Š!"ØÙà€þ€B,,ŒSÿ2}ìW-KË:;0EŒÿ
i‚¶;NM0F
I •Y$%&'(V¶·:;A·¸-‹MN!_S½0-)*PLWC ¹2º»å½uNL
Sy/"·¸åÔÕ˜>3À:;AMF
!_MÖ ×>¨ 0-)
I kJ"ûÃ|}~•€%BNCCNE-)*~•-—Ž7=M¹{-ÌÍ:;A3&YÔ
Õ‘–’â–(id0FPLWC Y¢(c(á¡¢&€-IuN*•Y¢(%)*xg-y
œ0 ASCO Y<=>ÎÏœ0,YVŒS*"++,-./NM0uA+ÓYÆÇ-Ái‹
)é Ö× > Bœ 0A àY ,Y Vd 0• +- • Î: ;A MF NCCN !" ÔÕ Ãx )
www.nccn.org
Vò‹@0•+iV/0F
19
†‡B1 Z\
I ÜóMÕ³•)*:-!"~•YÔÕ>êW:Á0èî>+_NM0F†‡B1)*l
_MÔÕîiƒkV;€*Ž‹p'ÔÕ67Ó;NM0•+>\Ûœ0AàYä„Y3‹
Vd0F†‡B1-ùéœ0~•)*l_MÔÕ*lê†l9á³ÕîŒÿiÎSû·:
;06h-Œ0f-*ÓYšA>)ËàN?@U;0F_Ž_*l_MÔÕiƒkV*;
€V*p'ÔÕ67,Ó;NM0+Mhq\)ŒMF
I ~•i†‡B1•Yùé>ãoœ0ëì)RÞd0F3yY~•-+uN)*†‡B1
iû·V/0Q?YÔÕÙÚcVd0Fp'ÔÕiÓY~•-+uN<kV)ŒMAà*
Ÿ_V,MMR•>¨0•+>-Ï_N*†‡B1YÉ{•Pid0+_N,*Ó;-Î
îœ0•+>?@à;0ÂÃiRMF†‡B1)!"ÔÕ>ƒ°:Á0Bl_YfòŒÿE
À3YèîVd0+Mh•+>½uNM0Aà*†‡B1-ƒ•Vùéœ0~•,M0F
†‡B1ŽUÎÏû•>¨0•+)ŒM+_N,*ÓYB1ùé-6uNМY!"~•
iû•>¨U;0Ž,_;ŒMF
I †‡B1-ùéœ0-)*~•)–(dÉ€-’0($(~B»fYÖ×ÂB+ÓY<
ÑE+Mh³ÒÒL>2;_Œ@;†ŒUŒMF–(dÉ€-’0($(~-LMN*Ü
ó)~•YÙÚc>kNÓº_N*~•ip'ÔÕ>ë¤_*l_MÔÕip'ÔÕ+9
Œ0F>ë¤V/06h-_Œ@;†ŒUŒMFÜó)*l_MÔÕY¢«%,kNÓº
_Œ@;†ŒUŒMF•;)p'ÔÕY¢«%+9Œ0,Y,d;†*9ŒUŒM,Y,
d0+-h;0FQa-*Üó)*†‡B1-ùéœ0Aà*<AY~•-QiïàU;
0Ž*lê†*½œ?.”Þ*|9*ÔÕ«–1—€ðŒÿ><Û_Œ@;†ŒUŒMF
~•)*~•YƒkP*†‡B1YxBÓY†‡B1iÿY6hŒ„…-d0ŽE*†‡
B1•YùéYão*B1
€-•Y‡U*"†‡B1>ò‹@0AàY¢(%Œÿ*†
‡B1-‹MN6S½UŒ@;†ŒUŒMF
"L6Š "ÔÕ Y•Ž ·
I "L6Š"ÔÕ)ˆAŒ•Ž·>Ð/Ñ•œFÔe-0(~(€ðV/0,Y,d;†*
ÚÛÔÕ>Hœ0,Y,d0F}R-*!"L6ŠÓYÔÕ-LMN6STU;0;%Ž
·>CœF•;UY"L6Š"ÔÕ-60•Ž·>‡ëœ0AàY!_MÖ×-‹MN)*
PLWC Y•Ž·‡ëY$%&'(>ùú:;AMF
Õ¡ F Õ¡)"~•*¹-á³Õî>?@NM0~•-LMN6STU;0FÕ¡+)*
)¡ði9:-ŸŒMþ;Vd0F)¡ð-)*â®YkNYy—-ó“>Ÿ
òñá(
•(BÖé܇Ei‚¶;NM0F)¡ðÞiŸŒœ•0+*â®Yy—iÕ—Œó“>
¨U;”*ýæ-#‹V/ŒSŒ0FÕ¡Y~•)Ò+•ÿi„;¶A)ר>*Ë0F
Õ¡-60„…).†Y‡-£ÙŒÊË>ÌÍ_*~•)"L6ŠÔÕ-60•Ž·+ô
h•+i35Æ_SŒ0F
20
„…F„…+)*Ò'Y—Ú¶A)„;Y•+V*"~•iQ,6SÑ1œ0UaVd0F
~•YÛÞ}Wiá³Õî¶A)ëìíÕî˜-„…>Ñ1_*ƒg"~•YQÝ 70%i
„…>Ñ1œ0F„…>*Ë0~•)*yÜY˜>°/”0+MuAݧŒ•+œUÞ«
–+ßSF"-60„…+ôh•+-‹MN*,u+6S½uN’_MF
àyY® ¦áoBàâ EFàâ)*àã+_N½U;0[Ö¿ÀYÛÜ*ày-®¦iä
/_A,YVd0Fàâk®Y 10%i"-6uNÐ/Ñ•:;A,YV*WPàâ+…†
;0F"£&àâ)Ò+•ÿi*"#"*øvxwBøvYx5E"*!"*Rƒ"*—
áÖ"¶A)å"Y~•V.Ë0F•;UY")®x-¦®>ä/:Á0Fàâ~•V)*
®•$é*àyY);di7*nà*¶A)LŒŽY»7*•M*Ë*—áÉo*Wo.
••*•ÓY¼á*æBçÛpqV«T>6hØ;>Ð/Ñ•œþ;E¶A)FTYØ;
i.Ë0ÂÃ,d0F
jM ¬Y ®¦ áo B¢ ( £L ØE F ®xY¢(£¦>ŸŠ**+gM•~+èhAàÁi‹3&Y¢(£‡L6Š¢(£´-¢(£¦B®¦Ei9:-ä/œ0+¢(£LØ
-Œ0F¢(£LØ)"Yäå¶A)ëìíÔÕYÎa-fÖœ0Š‹Pid7*d0M
)ÞéD¶A)ÞCa-fÖœ0•+,d0FQ,6Sd0¢(£âØY]^)*¢(£
´c³äåB¹-!"*fiz"¶A)“hØ-60ÂÃE*¢(£´•YëìíÔÕ*
KI"*§ê¶A)äê*+*¢(£´Y$%*¢(£p-.Ë0ûY•~ŒÿVd0F
`¿ À Y® ¦á o BW P dâ E F dâ)*ë—Œ®¦i*dãB`Yâ+dKY,Yì
,E-ä/_Aþ;Vd0FWPdâ)*dãV$%œ0"-6uNÐ/Ñ•:;0F"
~•YµÛÞ-dâi.Ë0FWPdâ>;œ0~•Y 75%çi*¢(£Ø*!"*`"
¶A)"#"Vd0FdâYgþ)*…ÙíîBïæ;E*¯PÃ*«T*dY•Þ_M
*Ë*ŸJiV/ŒM*ðñ*Bœ—iœr;ŒMEŒÿVd0F
òó F ëìíÕîL6Šá³Õî-60•Ž·+_N*òói.Ë0Š‹Pid0Fëì
íÕîÌŠá³Õî)*óô>.,:Á0óÎ>$%œ0•+-6uNòó>Ð/Ñ•œF
òó)*•y*¨*j*¬*PYR*˜yŒÿ*kâ-.Ë0+=êU;0Fóô)<k
-õ@˜º0ÂÃ,d;†*öA-õ@˜º0ÂÃ,d;†*y—¿-õ@˜º0ÂÃ,
d0FÂÃ-6uN)*óôie-§SŒ7BE-œpŽŒMÒÿE*»7iŒS*¯°
œÏ-Œ0ÂÃ,d0Fòó)oë¿L6Š*Ö¿-Æ_MÑ1V*~•YÓ|–•€1
L6Š.†Y‡-ÊËi.Ë0F_Ž_*òó)^:3E¿Œ,YV*óô)*Ò+•ÿ
YÂÃ*`Š.êNS0F
21
]þ ð& ÿ -¡ g F ]þð&ÿ-¡g)*¡˜þð&ÿ-G'i9:-]Mþ;Vd0F
]þð&ÿ-¡g).ÀYö÷>6hŠ‹Pid7*"-6uNQ,6STU;0_÷9
:V*"~•Y 10%(20%-.Ë0F]þð&ÿ-¡gY~•V)*‘’É“*Wo.•
•*øù.à«*™ú*Y$ÝN\&*„….ûØ.ü««*qýþ;Y¼áBþÿ*˜
ò#Ý*-=ÅÆŒÿEL6Š•«i.Ë0•+id0F•'Y]þð&ÿ-¡gV)*
ºRÊ* o!Yÿ;¶A)o[fŽ*Qa-)ÎÝ"˜L6Š#$i.Ë0Š‹Pid0F
*+ gF *+g)*;%Œ§ê*ÿ–ð«¶A)äêBùžêŒÿEi®x-Äà_*H
Ip-6uN&MŽ-O%:;ŒSŒuAE-.Ë0F"~•)*"L6Š"ÔÕB¹á³ÕîL6ŠV¶A)Î&ÛÜ•YëìíÔÕE-6uNHIpiضuNM0Aà*
*+g>Ð/Ñ•_MœMF*+gYgþ)*f¸B®'()'}WE*W*.f+*,
•«.™x#*à«*²&E«,_S)²&E-¸«¶A)\&*R”¶A)çÛ¿ÀY
A–;*öA)ïæ;*¹-æ7$¶A).$¿ÀYf)*ØT¶A)/«*9:Œ®
¹R¶A)Ž5TŒÿVd0F
OP- L@0 0C -g þF OPYQÝ 40%-*!"¶A)!"ÔÕ-670C-gþi
.Ë0F0C-gþ)ÔÕY4É--6uN9Œ0Ž,_;ŒMi*YÍÁ*1+*®Y
¯°.Ž5T.°±.—¬±*P-E«*23Ä´ÅÆ*kh‹œ—L6ŠÉ4Œÿi=
êU;0F!"YAàá³Õî>?@NM0÷ÑfOP)*Z567FMCÅV÷Ñœ0
ÂÃ,d0F
™ ãx Y A – ; Bý w # E F ýw#)™L6Š6YxÈY#gV*«T>6hMÙL6
Š™ãxYA–;>.Ë0Fá³Õî>?@NM0~•YQÝ 40%-.Ë0Fýw#)á
³Õî-6uNÎÏÐ/Ñ•:;0ÂÃ,d;†*á³Õî¶A)•SyÛÜ•Yëìí
ÔÕ-60HI™R-6uNÐ/Ñ•:;0ÂÃ,d0F
WoL6 Š.•• F••+)*7xg±>™ŽU볜0g8Vd0F•;)*®xŽU
;%Œ±‡>Z6œ0AàYÓùŒèîVd0FWo)••_AM+Mh¢M9JVd0F
Wo+••)*"á³Õî>?@NM0~•L6ŠëìíÔÕ>?@NM03y~•-L
MN6STU;0F"~•YRSi*ÔÕ-60ûYM”;Y•Ž·67,*Wo.••
>:;0+¹hF]gV&MŽ-ÔÕ_AÂÃ*WoL6Š••)ÒàNÉ;V)d0,
YY*£ÙŒUa+)ŒUŒMF‰@PY••)*òâ*4¤‡•<9:*®•žŸ*k
h‹*á³Õî”=>Ð/Ñ•œF
P#‹> %FP#‹>%)kNYu-6Sd0•+V*OPYQÝ 43%*ePY 31%-.
Ë0F"~•V)*ÔÕ*ØÙ¶A)«~´«YAàMuÓhRMF"Y;}-ŽŽhU
22
”*kNYuAi*PYUa>Ô#Ü-x~œ0•+>AàUuNM0FPYUa)*"
äå*á³Õî¶A)ëìíÕî-60⮿¼á*ïðñ(¼á*„…*«T*Wo.
••*P¿9JBP’E>klœ0_±Õî*`fY:?*«~´«*kh‹L6ŠÉƒ
-6uNÐ/Ñ•:;0•+iQ,RMFP#‹>%Ygþ)^:*’ï>%*@A>%*
³ð‘«->%L6Š«B>%Y 4 4É-—É:;0F
WXYU aF WX)RSYýÑ>‚ƒÖ×pVd0FÓYAà*WXYUa)Ð:Œ«T
>6hFWX)â®Y½È-d7*ûu-òê0Aà*RSY~•i*WXYUa-y:
œ0•+)¹-Æ_M•+>½0FWX)â®Yxy>*+gŽU50Aà*WXYUa
iûY£ÙŒUa-‹Œi0FûY•Ž·+ʈ-*Z[¶A)F-ÔÕiQ?Vd0F
û-*ÔÕL6Š.$Yä#-6uN/«L6Š.†Y‡iµ?:;0•+iRMFWX
YUa)*lê†á³ÕîŒY-•BIVE
—€ìŽUYC³B•;-6uN/«¶A)
-¸«iÐ/Ñ•:;0E*ëìíÔÕ-6uNÐ/Ñ•:;0WXDò¶A)¸$yW
X*â®Y3y—-3vªiŽŽ0•+-6uNÐ/Ñ•:;0ªîMÙB‡”;EŒÿ*
RˆŒ]^-6uNÐ/Ñ•:;0F
®•$ éF "ÔÕ˜-)®•žŸYèi3è¿Vd0i*®•i$éœ0~•,M0F"
ÔÕ˜YˆŽŒ®•$é)*^:UaŒMF_Ž_*‹ÛŒ®•$é)~•YÇÈL6Š
ÔÕ-yœ0EgP-ÊË>ÌÍœFá³Õî*«¬(–’ŒšAL6Šïðñ(Õî)
®•$é>Ð/Ñ•_h0F
ÔÕa
!"ÔÕi2;_AU*Ô#Ü+dÉ(€ö}„BÔÕaYÑÒôõEYÔÕtÄ-‹
MN@_ÃhF•YtÄ-)*aYÞéDL6ŠÞC,-L@0”å>ñ•n€œ0Aà
Yv-¿Œ.õMܳ¿|9i‚¶;0+=êU;0F!"dÉ(€ö}„ÔÕ-)*^
:*v-¿Œ.õL6Šà(ñáâdx€içè:;0FSh_MÓ;«;YÖ×)*ASCO
~•Ãxå!"-L@0dÉ(€ö}„ÔÕVò‹@0•+iV/0F
!")!o¶A)!o}½Yy—V`fœ0Š‹Pid0F"`fYgþ+_N*lA
Œ_•7i!ox*PYR*dK-ÁuN.Ë0•+*V«¶A)V³*•«¶A)@M
;•fŽ*¿PÃĶA)…Ù>%*Ò'Y„…*FÃiWM+*Ë0•+Œÿi!"U
;0F•;UYgþi.ËAU*Ô#Ü-x~œ0•+F`fYŠ‹P)*".z•,Y
æ^Y£oVd0F`fY:?+ôh•+-‹MNYGcV!_S³•VÒ_MFF
äåaB!oæZå¶A)!zØdc³åE*!o-$HiT7*åf+9Œ0:MÝ
/:-ŒuNM0Ž,_;ŒMFäåY3y+_N¢(£´ic³:;AÂÃ*d0M)
ÔÕ˜-ÊË>?@AÂÃ*¢(£âØBjY);di7Ei.Ë0ÂÃid0FPLWC
23
¹2º»å!"ÔÕaå¢(£âØYZ[BµIîTE*PLWC ¹2º»å!oæZåaå
½uNLSy/•+*PLWC ¹2º»å!"ÔÕaå!o`k*PLWC ¹2º»å!"Ô
Õaåum!oYÙÚ>3À:;AMF
ëìíÔÕ)`Yº»L6ŠíˆáB§á¶A)D©E>Ð/Ñ•œŠ‹Pid0Aà*
3yY~•V)*ëìíÔÕ2;ŽU 2(3 JDa-*ïæ;*¯PÃMd«i.Ë0•+
id0F•;UYgþ)^:3E¿Œ,YVd0FëìíÔÕa-l_MgþifÖ_A
ÂÃ*d0M)•Ž·i—K_ŒMÂÃ*Ô#Ü-x~œ0•+il¶_MF
nñc&d2(-6uNøv"¢«%i$Ý_h0Aà*nñc&d2(>‰·_NM
0OP~•)*C 1 ”Yx.>?@0y/Vd0FÉz³¡>)Ëà+œ0l_MgþœpMAÂÃ*Üó¶A)LrM-8ê0•+Fö!«~(§€ð*'%$•«n(¶A
)´~(§€ð+MuAö(àn€ø²%Œ>‰·_NM0OP)*•;UY_ŒiV>
NØá_*VO>žŸ:Á0Aà*ÔÕD·fL6ŠÔ#Ü-6uNÔàU;0+/-*
Vm'>¯vœ0•+>Ôà0F
!"ŽU”å_AOP)*ÇÈYAàY{i:;A‘–’â–(-Ih•+Flê†*
ÇÈ¿Œ®•L6ŠÇÈ¿Œ‘.†>ˆ‰œ0•+*çè:;A"«%¢€•(á|9>
?@0•+Vd0FdŒAY¦H-duAQ?YtÄ>iN0Aà*Ô#Ü+@_Ãh•
+FÔ#Ü)*dŒAY¦H*⮿‹JL6ŠÇÈþ;-©ª/*ƒkŒŸJtÄ>i
N0Y>ä8h•+iV/0F"YaYÇÈŒ.†YGcV,u+!_S³•VÒ_MF
•Y$%&'(V¶·:;A·¸>½0Aà-*PLWC ¹2º»å½uNLSy/"·
¸åÔÕa>3À:;AMF
Ö×Yj k
I !"jk)MAƒ•VM0F}R-Cœƒ°¿Gc)*”ù+_N†‡B1-LMN|
ŘVd0Ž,_;”*ÖEFV)m<=Vû·V/ŒMŽ,_;ŒMF./L6ŠÔÕ
ÙÚc-‹MN*Ô#Ü-M‹V,x~œ0•+F
µoä åF st>T_*OH>Z[œ0l_Mäåèîi†‡B1V|Å:;NM0FW
X>Tœ!oæZå-6uN*!"#$%&'()äå67,OHiŸŒSŒ0+=êU;
0F
y —! o ú ì F y—!oúì+)*ÎÏØÙÛÜ-úìœ0ëìíÔÕVd7*^:)*
!zØdc³åa-*p'¿ëìíÕî>·MNð€
(Vgh;NM0k!oúìY_
h7-gh;0F•YÔÕ)½yëìíÔÕ¶A)xyëìíÔÕ-6uNgh•+iV
/0FxyúìÕî)*ëìí>ÎÏØÙyš-úìœ0èîVd0F•YÔÕV)*!
o-3E¿-ßà_A„â«
}%þ¬€¬ðY˜-ëì†P>;œ0„:Œ0´}~>
à;*•;i!"Yxy¶A)pq-{àæ¶;0FØÙÛÜ•ëìí>67ÎÏ¿-ú
24
ìœ0•+-6uN*~•-¦H+:;0ëìíÕî…gÃtE,i•y:;0+=êU
;0FIœY½yúìëìíÔÕ> 6 w,ghp'ÔÕ+y—!oúì> 1 w,ghÔÕ
+>€‚œ0AàYÝ9BŒkK†‡B1i 2005 C-·¶uAF
¢'¼Ä ëìí ÔÕB In te n si ty- mo du l ate d radi ati on the r apy: I M RT EFIMRT
)*!o•Y½yúìëìíÕî>ghAàY67ƒ•–èîVd0F!o-úì:;0
ëìíY¢'>¼á:ÁN*IœYëìíÔÕ67,z{-ØÙ>PUM*!ostk®
-Ž3Œëìí—QVúì_*ÇÈŒst•Y$%>”=œ0FIMRT V)*o[M`Œÿ
•H[Öpq•YíOiž:;*ÔÕ˜YWXDò+MuAœr-Ñ•0•Ž·Y¢«%
i]ž:;0+=êU;0F•Y•+)*„:Œ!o>‰‹OP+€yNWXDòŒÿY
•Ž·¢«%iÝ/M!o•–—i˜ñŒM_Ý/ŒOP-+uN*¹-•HVd0F
IMRT -6uN,*67}fYúì‚åV6SòU;A!ost•Y,-Ž·*lê†*§
á*);di7*¼hŒÿi]ž:;0+=êU;0F
á³Õî *ï ðñ( ÕîL 6Š. ±Õî Fá³Õî*ïðñ(ÕîL6Š.±Õî-L
@0l_M_±L6Šn·i†‡B1V|Å:;NM0F
Üó-R P0y /‡U
I dŒAYÇȇë-‹MN*<Û-©ªSãv>ghhêV*Ô#Ü+:-&S>‘7
duNLS•+i•HVd0FaY‡U>Ô#Ü-RP0•+>Ôà0F
G”äå f-* !z½ ÕÜ- RP0 y/‡ U
dŒA)=vÜVœŽT
•Y4Yäå>¨Î+_NM¶œŽT
‹i=êNM06hŒäå)*•;¶VQU•…:;¶_AŽT
•Yäå>?@0f-*û-QŽ|9>?@Œ@;†Œ7¶Á•ŽT
!"Y»->VêN,Uê¶œŽTÓ;)Q>ÎÏ_¶œŽT
!zØdc³å>?@U;¶œŽT
!oæZåi¦HVœŽT,_ÓhŒU*ÊE-!o`kåB:w½ÕäåE>gh•+
>Ôà¶œŽT
PYRY¢(£´)æZœ0y/V_WhŽT
$(
|ð¢(£´.|+)QVœŽTÓYû•+ö÷P)QVœŽT‹-Ó;>Ôà¶
œŽT
$(
|ð¢(£´.|-6h¢(£LØY¢«%)QVœŽTPQ¢(£´æZV)ÿ
hVœŽT
äåf-á³Õî>=ê0y/V_WhŽT
25
M‹äå-‹MNYãv>œ0¦Hid7¶œŽT
äåY·Î+_N*Q>œy/V_WhŽTäåf-¢â}%«œ0Aà-Ái‹èî>
VêNMA–@¶Á•ŽT
ÿYÜ_`M•„¢•(~Y‰·>˜µœy/V_WhTïðñ(78Õî)˜µœy/
V_WhŽTÑ™=/_-‹MN)MŽiV_WhT
äå)ÿ;SUMŽŽ7¶œŽT
äå˜*dŒA)Q>ghYŽ*QXghYŽ>z{-<Û_NS–:M¶Á•ŽT
•Yäå-)*ÿY6hŒYZi¦HVœŽT
$)ÿ•-T7¶œŽTÓ;)ÿY6h-òê¶œŽT
•YäåY¢«%+•Ž·)QVœŽT
äåaY•Ž·>[\œ0Aà*QiV/¶œŽT
äå-£_N*Q>-ÏV/¶œŽT
.•YäåYAà*à›)¦HVœŽT,_¦HŒU*à›-,)ÿ;SUM-Œ7¶œ
ŽT
.†‡|9R•i³0¶V-*ÿ;SUMÏAŒ@;†Œ7¶Á•ŽT‹i4@_¶œŽ*
Ó;+,dŒAi4@_NS–:M¶œŽT
.»ëÜist>|9_*×®]>]SYVœŽTüiÓY×®]>‹-<Ûœ0YVœ
ŽT
.•Y6hŒäåV=êU;0Ãng)QVœŽTUaid0ÂÃ*ÿY6h-_AU½
0•+iV/¶œŽT
.äåa*”åœ0¶V-ÿ;SUME,iŽŽ7¶œŽT
.^Ã_*«¬€„ðM`¹iý·:;¶œŽT
.äå-60¾@¿ŒÊË)d7¶œŽT
.‰ºa0•+YV/0<Û]Måa–öY£(d´}~)d7¶œŽTM‹-ŒuAU
&,•€>bŠ*àbœ0•+iV/¶œŽT
.½Õ¿²¦î>gh¦Hid7¶œŽT•Y•+)Q>ÎÏ_¶œŽT
.dÉ(€ö}„YAà*`œ›œ0¦Hid7¶œŽT
G”äå a-! z½Õ Ü-R P0y /‡U
‹Y"Yn–„)QVœŽT
ØÙYÝ/:>VêNS–:MF
»¼Yá´€’+»->VêNS–:MF•;)Q>ÎÏ_¶œŽT
»ë×®]B†‡|9R•E>‹-<Û_NS;¶œŽT
»ë×®]Y0"€>,Uê¶œŽT
äåV")ky‘7ZŽ;¶_AŽT
")¢(£´d0M)®xYÿ•Ž-KI_NM¶_AŽT
26
‹YØÙYïðñ(þ;)ÿhV_AŽT•Y•+)Q>ÎÏ_¶œŽT
HER2 Yþ;)ÿhV_AŽT•Y•+)Q>ÎÏ_¶œŽT
)éäå>œ0¦Hid7¶œŽT
ûYÔÕ*lê†á³ÕîMëìíÕî>?@0¦Hid7¶œŽT
)éÔÕYD·-‹MN*M‹ãvœ0¦Hid7¶œŽT
ûYÜó-òN,Uhy/VœŽTcNBÜóY
fE_NMA–@¶œŽT
ØÙxÕ Ü-R P0y /‡U
‹Y"Yn–„)QVœŽT
ØÙYÝ/:>VêNS–:MF
»¼Yá´€’+»->VêNS–:MF•;)Q>ÎÏ_¶œŽT
ØÙYïðñ(þ;)ÿhV_AŽT•Y•+)Q>ÎÏ_¶œŽT
HER2 Yþ;)ÿhV_AŽT•Y•+)Q>ÎÏ_¶œŽT
®xYÿ•Ž-"id0ŽÿhŽ>Äy0AàY)é|9>?@0¦Hid7¶œŽT
‹YZa)ÿhV_WhŽT
ÔÕÙÚc+_N)Qid7¶œŽT
á³Õî+)QVœŽTïðñ(Bx—¬EÕî+)QVœŽT.±³¿Õî+)QVœ
ŽTp¿Õî+)QVœŽT
Ó;«;YÔÕÙÚc-)‹-+uNÿY6hŒ;•Pid7¶œŽT¢«%)QVœ
ŽT
‘ÔÕÙÚc-‹MN*ÿY6hŒ«–1—€ðiZ5:;¶œŽT
$þ(’³"•³(>?@0y/VœŽT
ÿY6hŒ†‡B1-ùéV/¶œŽT
•YÔÕ>?@0'(+_N*‹-QiV/¶œŽT
•YÔÕ-‹MN=êU;0•Ž·)QVœŽT
•Ž·>[\œ0Aà-QiV/¶œŽT
•YÔÕ-6uN*‹YM:.†)ÿY6hŒÊË>?@0V_WhŽTd»MŸJ)V
/¶œŽ*^:Y†J>gê¶œŽT
ÔÕ˜*ÿY6hŒ.†ˆØY¼0>=ê0y/VœŽT
ôYó)õ@¶œŽT
•YÔÕ).%‹JBМøB>‰0‹JE-ÊË>ÌÍ_¶œŽT.%‹J-yœ0¢
«%i]SŒS*ÊñY;€P>CœÔÕ)*û-d7¶œŽT
÷Ñ_NM0•+Bd0M)÷Ñ_NMŒM•+E)*ÔÕÙÚc-ÿY6hŒÊË>Ì
Í_¶œŽT
ÔÕ-‹MNYã/>œ0¬-*!"YÆÇÈ>=Æœy/V_WhŽT
‹YÔÕ-£_NUa¶A)‡Uid0ÂÃ*ü-4@œ0•+iV/¶œŽT
27
‹Ybê+Œ0*Ö¿en)ü-ïà0•+iV/¶œŽT‹YÆÇ)*ü-ïà0•+
iV/¶œŽT
ÔÕa-"i`f_AÂÃ*ÿY6h-_N¼/_¶œŽT
ÔÕ2;a*dÉ(€ö}„ÔÕtÄ)ÿY6h-Œ7¶œŽT
.ÜóY.õ>?@0\')ÿYL'-Œ7¶œŽT
.ÿY6hŒ|9i¦H-Œ7¶œŽT
.Ó;UY|9>?@0\')ÿYL'VœŽT
.‹Y†‡|9R•>0"€>,Uê¶œŽT
ëìíØ ÙÜ- RP0 y/‡ U
ëìíÔÕ+)QVœŽT
•YÔÕYcp)QVœŽT">—6œ0•+VœŽT
•YÔÕ-6uN"Y`fiZ[:;0òæT)ÿ;SUMVœŽT
ëìíÔÕ)ÿYL'Y\'Vgh;0•+-Œ7¶œŽT
1 ”YÔÕ-ŽŽ0E,)ÿ;SUMVœŽT
ÔÕ)›”ÊËVœŽTëìíO¶A)úìÛÜ)ÔÕ-,˜-¼h7¶œŽT
•YÔÕYAà-'(V/0•+)QVœŽT
•YÔÕ-6uN*‹YM:.†)ÿY6hŒÊË>?@0V_WhŽTd»MŸJ)V
/¶œŽ*^:Y†J>gê¶œŽT
ëìíÔÕ>?@A+/-‹iÑ1œ0+Z5:;0•+><Û_NS;¶œŽTÓ;6uNYWÊË)d7¶œŽ*d0M)ÔÕ˜-É;*>Bê¶œŽT
•YÔÕ-6uN.Ë0Š‹PYd0•Ž·)QVœŽT•Ž·)ÿY6h-_N\U"
0•+iV/¶œŽT
ëìíÔÕ˜*‹YWX)ÿY6h-Œ7¶œŽT›M*ÿY6hŒ«c(–öÞ`>¶
h•+iV/¶œŽT
Mf>bŠ0•+-‹MN*o¥œ0¦H)d7¶œŽT
‘yN)ŒUŒM‘±*•ný(¶A)•„¢•(~)d7¶œŽT
ÔÕ˜*m³’â(~Œ¶A)f+klŒY¶·>=@0y/V_WhŽT
•YÔÕ-6uN.Ë0Š‹PYd0,-Ž·)QVœŽT
`käå>?@0ã/>_AÂÃ*ÓY•+-6uNÔÕtÄ-ÿY6hŒÊËi.˶
œŽT
•YÔÕ)*.%‹J-ÊË_¶œŽT
ëìíÔÕ>?@NM0~•-ê@NY¹ãŒ•€•«*lê†*gh¶A)gh[Ý
Y•€•«Œÿ)d7¶œŽT
:w½Õ Ü-R P0y /‡U
28
dŒA)=vÜVœŽT
!o`kå>ÚÛ+_NM¶œŽT
C-QUY!o`käå>guNM¶œŽT
.õ>2êN*‹)!o`kå-êMNM¶œŽT
!o`k-LMN*ÿY6hŒÙÚcid7¶œŽT
Ó;«;Y4É-‹MN*,Ì+•Ì>VêNS–:MF
`kå)M‹?@U;¶œŽT
!z½ÕÜ+Äiœ0¦Hid7¶œŽT
ëìíÔÕ>?@NM0ÂÃ*Ó;-6uN`kåYÙÚc)¼h7¶œŽT
st¾»ÖB¬x}&—'c«£(€€E+)QVœŽT‹-)Ó;i¦HVœŽT
ÿY6hŒum!o>¶M¶œŽT.ë‘jâM&¢0(>¶M¶œŽT
Ó;«;Y,Ì+•Ì)QVœŽT
ÿYn–„Yum!o>Ôà¶œŽTÓYëì)QVœŽTÿY•–—VœŽT
!o>`kœ0Aà-*â®YãŒy—Yst>¶·œ0ÂÃ*ÿYy—ŽU‰uNS0
•+>Ôà¶œŽTQXVœŽT
,_!oæZåL6Šum!o`kå>?@0ŒU*!TY`kå,?@U;¶œŽT?
@U;0YŒU*M‹?@U;¶œŽT
!o`kå-ŽŽ0k·)ÿ;ÒÿVœŽTÿ•¶Vq÷iû/¶œŽT
äåE,)ÿ;SUMVœŽT
äå'(+_N¦HŒ,Y)QVœŽT
•Yäå-)ÿY6hŒYZi¦H-Œ7¶œŽT
åa*Q>-ÏV/¶œŽT
.à›-,)ÿ;SUM-Œ0V_WhŽT
.•Y4Yäå-=êU;0Ãng)QVœŽT
.”å-)ÿ;SUMŽŽ7¶œŽT
.ŸJ>‚ƒ^:Y†J>M‹`DV/¶œŽT
.½Õ¿²¦î>gh¦Hid7¶œŽT•Y•+)Q>ÎÏ_¶œŽT
.^Ã_*«¬€„ð(ï
}c«Y6hŒ±VWX>÷Ë0,Y)M`¹i·MU;¶œ
ŽT
.äå-6uN*OHŒÿ¾@¿ŒÊË).˶œŽT
.‰ºa0•+YV/0<Û]Måa–öY£(d´}~)d7¶œŽT
.dÉ(€ö}„YAà*M‹`œ›_Œ@;†Œ7¶Á•ŽT
ÿY6hŒR•>-ÏV/¶œŽT
`kilè–@YÂÃ*Ý/:M:)±yÈY!o+Ä\_¶œŽT
`k!o-ß0+*ÿY6hŒ*Ëi_¶œŽT
`k!o)ÿ•Œ*BV_WhŽT
29
E,iÑuAÂÃ*`k!o-ÿY6hŒ¼ái.Ë0•+iZ5:;¶œŽT
М*`'äå>?@0¦H)d7¶œŽBlê†*um!oY‘7±êŒÿEF
®•i¼á_AÂÃ*QiZ¯:;¶œŽT
М/0_AÂÃ*ÿY6h-Œ7¶œŽT
.%ÜÕ ÚÛÆ -RP 0y/ ‡U
!"+./:;A~•)*МøB>‰N0ŽÿhŽio¥ŒÂÃ*WºYÜó-éêN*
ÔÕ-miº*.%ÜÕÚÛÜ-60.õ>?@0•+il¶_M+=êU;0F
"~•-ö’f–«œ0\')ÿ;SUMVœŽT
•Y"ÔÕ)Ö×¶A)МY.%‹J-ÊË>ÌÍ_¶œŽT
,_ÓhŒU*‹Y.%‹J>qzœ0Aà-*ÿY6hŒÙÚcid7¶œŽT
‹iùéV/ÓhŒ†‡B1)QVœŽT
.%‹J>qz_6h+BT0•+-6uN*"ÔÕY;€PiŒŒh;0•+)d7¶
œŽBlê†*‹Y!"-ÊË>ÌÍœ•YÔÕ-¶·:;0ïðñ(-60¢«%)d
7¶œŽ*d0M)•YÔÕ>?@0Aà-"ÔÕib¸œ0¢«%)d7¶œŽET
"ÔÕYa*/0>BT0¶Vÿ;ÒÿÏAŒ@;†Œ7¶Á•ŽT
á³Õî¶A)ëìíÕî>?@NM0-,-/0V/¶œŽTÔÕ˜-/0_AU*ÿ
hŒ7¶œŽTmnP9:MoYM‹•Y$%¢«%)d7¶œŽT
.%‹J>qzœ0Aà-‹iÙÚ_Aèî-ŽŽ0k·)MSUVœŽTq÷)ÿ•¶
Vû/¶œŽT
!_MÖ×-‹MN)*ASCO ~•Ãxå.%‹JYqz>3À:;AMF
~•Ö× ¢ž€ «
American Society of Breast Disease
PO Box 140186
Dallas, TX 75214
Phone: 214-368-6836
www.asbd.org
Breastcancer.org
111 Forrest Ave., 1R
Narberth, PA 19702
www.breastcancer.org
Breastlink
30
23430 Hawthorne Blvd., Ste 340
Torrance, CA 90505
Phone: 310-791-6610
www.breastlink.com
Fertile Hope
65 Broadway, Ste. 603
New York, NY 10006
Toll Free: 888-994-HOPE (888-994-4673)
www.fertilehope.org
FORCE: Facing Our Risk of Cancer Empowered
16057 Tampa Palms Blvd. W, PMB 373
Tampa, FL 33647
Toll Free Helpline: 866-824-RISK (7475)
Toll Free: 866-288-7475
Phone: 954-255-8732
www.facingourrisk.org
HER2 Support Group
6973 Mimosa Dr.
Carlsbad, CA 92009
Phone: 760-602-9178
www.her2support.org
Inflammatory Breast Cancer Research Foundation
321 High School Rd. NE, Ste. D3 #149
Bainbridge Island, WA 98110
Toll Free: 877-STOP-IBC (877-786-7422)
www.ibcresearch.org
Living Beyond Breast Cancer
10 E Athens Ave., Ste. 204
Ardmore, PA 19003
Toll Free: 888-753-LBBC (888-753-5222)
Phone: 610-645-4567
31
www.lbbc.org
Mothers Supporting Daughters with Breast Cancer
25235 Fox Chase Dr.
Chestertown, MD 21620
Phone: 410-778-1982
www.mothersdaughters.org
National Breast Cancer Coalition
1101 17th St., NW, Ste. 1300
Washington, DC 20036
Toll Free: 800-622-2838
Phone: 202-296-7477
www.stopbreastcancer.org
National Cancer Institute
Public Inquiries Office
Bldg. 31, Rm. 10A31
31 Center Dr., MSC 2580
Bethesda, MD 20892
Toll Free: 800-4-CANCER
Phone: 301-435-3848
TTY: 800-332-8615
www.cancer.gov
National Comprehensive Cancer Network
500 Old York Rd., Ste. 250
Jenkintown, PA 19046
Phone: 215-690-0300
www.nccn.org
National Lymphedema Network
Latham Square
1611 Telegraph Ave., Ste. 1111
Oakland, CA 94612
Toll Free: 800-541-3259
32
Phone: 510-208-3200
www.lymphnet.org
Nueva Vida, Inc.
2000 P St., NW, Ste. 740
Washington, DC 20036
Phone: 202-223-9100
www.nueva-vida.org
SHARE: Self-help for Women with Breast or Ovarian Cancer
1501 Broadway, Ste. 704A
New York, NY 10036
Toll Free: 866-891-2392
Phone: 212-719-0364
www.sharecancersupport.org
Sisters Network, Inc.
8787 Woodway Dr., Ste. 4206
Houston, TX 77063
Toll Free: 866-781-1808
Phone: 713-781-0255
www.sistersnetworkinc.org
Susan G. Komen for the Cure
5005 LBJ Freeway, Ste. 250
Dallas, TX 75244
Toll Free: 800-IM-AWARE (800-462-9273)
Phone: 972-855-1600
www.komen.org
Y-ME National Breast Cancer Organization, Inc.
212 W Van Buren, Ste. 1000
Chicago, IL 60607
Toll Free: 800-221-2141 (English)
Toll Free: 800-986-9505 (Spanish)
Phone: 312-986-8338
33
www.y-me.org
Young Survival Coalition
61 Broadway, Ste. 2235
New York, NY 10006
Toll Free: 877-YSC-1011 (877-972-1011)
Phone: 646-257-3000
www.youngsurvival.org
PLWC Y~•Ö×¢ž€«Yk®>ò0F
34